Alzheimer’s disease (Late onset)

AD_LO

Alzheimer's disease: A progressive, neurodegenerative disease characterized by loss of function and death of nerve cells in several areas of the brain leading to loss of cognitive function such as memory and language.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F00.1, F00.10, F00.10G30.1, G30.1, G30.1+F00.10 Cause of death:* ICD-10 — F00.1, F00.10, F00.10*G30.1, G30.1, G30.1+F00.10 2 out of 7 registries used, show all original rules.	9974
4. Check minimum number of events None	9974
5. Include endpoints None	9974
6. Filter based on genotype QC (FinnGen only)	9974

Control definitions (FinnGen only)

Control exclude: G6_ALZHEIMER

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	AD_LO
CONTROL_EXCLUDE	G6_ALZHEIMER
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F001\|G301
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F001\|G301
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Alzheimer’s disease (Late onset) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Alzheimer’s disease (Late onset), excluding more controls

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	9974	4828	5146
Unadjusted period prevalence (%)	1.97	1.65	2.27
Median age at first event (years)	80.66	80.70	80.61

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
7167: Matched controls
66310

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N06DA02

ATC

donepezil; oral

48.5

323.0

3643

1383

G30.0

ICD-10 Finland

Alzheimer disease with early onset

331.3

323.0

409

G30

ICD-10 Finland

Alzheimer disease

67.9

323.0

606

G30.8

ICD-10 Finland

Other Alzheimer disease

24.5

323.0

626

258

N05AX08

ATC

risperidone; systemic

10.7

323.0

2009

2329

F0019, G301

ICD-10 Finland

+∞

323.0

528

G30.1

ICD-10 Finland

Alzheimer disease with late onset

372.7

323.0

5855

783

SPAT1053

SPAT

Memory test

3.4

323.0

2684

9886

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

96.3

323.0

3273

575

P70

ICPC

Dementia

18.1

323.0

912

529

N05AH04

ATC

quetiapine; oral

5.0

323.0

1577

3533

F00.10*G30.1

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

118.5

323.0

2616

320

F00.10

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

108.9

323.0

1140

115

P20

ICPC

Memory disturbance

6.5

323.0

3152

7190

N06DA04

ATC

galantamine; oral

18.7

323.0

929

523

F03

ICD-10 Finland

Unspecified dementia

6.8

323.0

1381

2264

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

194.3

323.0

2024

134

N06DX01

ATC

memantine; oral

64.5

323.0

4373

1569

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

7.2

323.0

2026

3456

N06DA03

ATC

rivastigmine; oral, transdermal

31.9

323.0

2182

898

F00.00*G30.0

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

220.4

280.7

297

A28

ICPC

Limited function/disability NOS

2.7

271.3

2386

10200

R41.3

ICD-10 Finland

Other amnesia

7.2

262.9

686

955

F009, G309

ICD-10 Finland

1117.7

233.7

234

F00.9

ICD-10 Finland

Dementia in Alzheimer disease, unspecified

33.1

215.0

292

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

11.4

196.4

388

331

R53

ICD-10 Finland

Malaise and fatigue

2.4

189.0

2096

9787

N05BA04

ATC

oxazepam; oral

2.3

168.1

2066

10033

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.1

167.6

2814

15697

F06.7

ICD-10 Finland

Mild cognitive disorder

5.1

165.1

564

1089

SPAT1245

SPAT

Provision of support and information to patient’s family members

3.7

164.6

808

2212

N06AX11

ATC

mirtazapine; oral

2.1

151.2

2247

11777

WYA20

NOMESCO Finland

Home visit

7.4

146.9

373

490

SPAT1216

SPAT

Assessment of functional ability

2.2

133.9

1769

8721

N02BE01

ATC

paracetamol; systemic, rectal

2.0

123.6

5751

44440

F0009, G300

ICD-10 Finland

+∞

119.6

118

F0014, G301

ICD-10 Finland

+∞

119.6

118

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.7

118.0

930

3499

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.4

115.4

1125

4755

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.1

115.2

1512

7357

N06AB10

ATC

escitalopram; oral

2.5

114.3

999

3979

F001, G301

ICD-10 Finland

165.3

114.0

123

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

113.1

2742

16815

SPAT1234

SPAT

Support of social functional capacity

3.0

111.5

719

2379

F05.1

ICD-10 Finland

Delirium superimposed on dementia

12.2

110.1

209

163

TAB00

NOMESCO Finland

Lumbar puncture

5.3

110.0

358

649

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

3.2

108.5

646

2021

F00.14

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms of mixed type

103.5

107.6

121

F00.00

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

68.9

99.1

117

F00.1

ICD-10 Finland

Dementia in Alzheimer disease with late onset

143.5

98.1

107

N05AH03

ATC

olanzapine; systemic

4.6

93.7

347

723

N03AG01

ATC

valproic acid; systemic, rectal

3.7

93.6

437

1130

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

5.9

91.4

272

442

F00.19

ICD-10 Finland

Dementia in Alzheimer's disease with late onset without information about additional symptoms

106.3

91.1

102

R41.0

ICD-10 Finland

Disorientation, unspecified

3.3

87.0

475

1390

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.8

83.6

1760

10069

A04

ICPC

Weakness/tiredness general

2.0

82.1

1167

5773

SPAT1254

SPAT

Administration of medicine

1.9

80.5

1395

7443

N05BA06

ATC

lorazepam; systemic, sublingual

2.8

79.9

548

1873

AA1AD

NOMESCO Finland

CT of head and brain

1.7

78.1

2078

12742

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

76.9

1499

8320

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.9

76.1

519

1766

F00.20

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

8.0

75.5

180

214

A06AD11

ATC

lactulose; oral

1.8

74.4

1668

9676

L28

ICPC

Limited function/disability (L)

1.8

74.0

1581

9029

Z75.5

ICD-10 Finland

Holiday relief care

5.5

72.9

227

390

N06AX26

ATC

vortioxetine; oral

4.0

68.3

292

697

130

Kela drug reimbursment

Malignant tumour

0.3

65.4

149

4380

N06AB04

ATC

citalopram; systemic

1.8

65.3

1380

7809

SPAT1360

SPAT

Extensive global examination

2.3

64.8

694

3014

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

4.5

63.0

237

501

F00

ICD-10 Finland

Dementia in Alzheimer disease

13.8

63.0

112

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

59.8

1247

7002

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

59.6

1239

6950

F0011, G301

ICD-10 Finland

+∞

56.7

XA800

NOMESCO Finland

Neuropsychological investigation

4.4

56.2

215

462

Z01.9

ICD-10 Finland

Special examination, unspecified

2.6

56.2

434

1585

S72.0

ICD-10 Finland

Fracture of neck of femur

2.3

54.6

560

2374

R55

ICD-10 Finland

Syncope and collapse

1.8

53.8

1041

5685

Z02.4

ICD-10 Finland

Examination for driving licence

0.6

53.6

931

13472

S01.0

ICD-10 Finland

Open wound of scalp

2.1

52.1

632

2891

N02AA05

ATC

oxycodone; systemic

1.7

52.1

1339

7973

N05AD01

ATC

haloperidol; systemic

2.8

51.2

362

1255

U04

ICPC

Incontinence urine

2.4

50.6

479

1951

F0029, G308

ICD-10 Finland

+∞

48.6

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

2.6

47.5

368

1346

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.8

47.0

952

5258

J01DB01

ATC

cefalexin; oral

1.5

46.6

4713

37764

SPAT1246

SPAT

Screening of depression or other psychiatric problem

3.7

45.8

213

548

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.3

44.7

435

1792

S06.0

ICD-10 Finland

Concussion

1.9

44.6

679

3395

N07AA05

ATC

417.0

43.9

F00.11

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly paranoidism

44.9

42.2

H02AB02

ATC

dexamethasone; systemic

0.4

42.1

145

3560

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

2.1

41.1

523

2431

SPAT1101

SPAT

Orthostatic test

2.1

40.2

503

2323

I95.1

ICD-10 Finland

Orthostatic hypotension

2.2

39.0

431

1886

SPAT1172

SPAT

Guidance concerning hydration

2.6

38.4

303

1120

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.8

38.2

729

3932

R42

ICD-10 Finland

Dizziness and giddiness

1.5

38.1

1712

11566

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.7

37.6

958

5639

AXX01

SPAT

3.6

37.4

175

453

SPAT1252

SPAT

Overall medication plan or its review

1.9

36.5

626

3258

S70.0

ICD-10 Finland

Contusion of hip

2.3

35.6

348

1435

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.1

35.6

445

2052

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

0.6

35.2

779

10812

F21

ICPC

4.2

35.0

139

312

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.6

34.8

260

933

W19

ICD-10 Finland

Unspecified fall

1.8

34.5

669

3622

F05.9

ICD-10 Finland

Delirium, unspecified

2.8

34.5

239

819

A29

ICPC

General symptom/complaint other

1.7

34.5

812

4663

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

34.1

2352

17180

J01CA08

ATC

pivmecillinam; oral

1.4

33.6

2053

14661

SPAT1153

SPAT

Removal of sutures

0.7

33.1

1175

14880

Z29

ICPC

Social problem NOS

3.5

33.0

159

423

N30.0

ICD-10 Finland

Acute cystitis

1.6

32.5

950

5782

F01.2

ICD-10 Finland

Subcortical vascular dementia

5.5

32.3

169

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

2.1

32.2

394

1799

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

3.7

32.1

147

375

B03BA03

ATC

hydroxocobalamin; parenteral

1.8

31.8

595

3182

N06AB06

ATC

sertraline; oral

2.0

31.8

409

1910

SPAT1304

SPAT

Counselling and guidance related to ageing

1.7

31.7

776

4499

R41

ICD-10 Finland

Other symptoms and signs involving cognitive functions and awareness

4.8

31.7

109

212

F00.12

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset, other additional symptoms, mainly hallucinations

50.5

31.1

SPAT1301

SPAT

No procedures

1.4

31.0

2160

15742

F00.13

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly depression

81.4

30.7

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

30.5

957

5921

F0012, G301

ICD-10 Finland

+∞

30.3

C10AA01

ATC

simvastatin; oral

1.3

30.3

3679

29268

Z02.7

ICD-10 Finland

Issue of medical certificate

2.0

29.6

421

2043

SPAT1251

SPAT

Organisation of medication

2.1

28.9

346

1568

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.1

28.8

347

1576

N05AD03

ATC

melperone; systemic

3.0

28.1

169

530

E86

ICD-10 Finland

Volume depletion

2.3

27.8

259

1047

F00.09

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset information on additional symptoms is lacking

59.4

26.9

G04CA02

ATC

tamsulosin; oral

1.3

26.4

2291

17195

SPAT1229

SPAT

Assessment of need for aid

1.6

26.0

698

4141

F00.01

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly paranoidism

130.0

25.8

J01EA01

ATC

trimethoprim; systemic

1.4

25.5

1706

12263

SPAT1139

SPAT

Nutrition survey

2.2

25.3

257

1083

A03FA01

ATC

metoclopramide; systemic, rectal

0.7

24.6

646

8718

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.8

24.0

448

2388

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.1

23.9

284

1285

Z2445

NOMESCO Finland

Psychologist

3.4

23.8

120

333

KMAK

NOMESCO Finland

1.3

23.5

2060

15417

R1250

NOMESCO Finland

Evaluation of functional capability

3.2

23.1

125

366

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.6

22.9

579

3378

F0013, G301

ICD-10 Finland

+∞

22.2

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

0.2

22.1

1176

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.9

22.1

329

1625

F01.20

ICD-10 Finland

Subcortical vascular dementia without additional symptoms

3.6

21.8

100

258

4912B

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]

0.2

21.7

848

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

2.4

21.5

191

754

A98

ICPC

Health maint/preventive medicine

1.3

21.4

5060

43048

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

0.1

21.4

757

-2

ICPC

4.0

21.4

207

SPAT1276

SPAT

Outlining of treatment with patient or their family members

2.3

21.3

201

817

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

0.2

20.9

1090

F01.29

ICD-10 Finland

Subcortical vascular dementia without information on additional symptoms

5.3

20.8

112

A04AA02

ATC

granisetron; systemic, transdermal

0.3

20.7

1561

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

1.9

20.7

327

1649

E0000UV

ATC

1.3

20.6

2070

15739

N02AJ06

ATC

codeine and paracetamol; systemic

0.7

20.5

1030

12472

F009, G301

ICD-10 Finland

+∞

20.2

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

1.4

20.2

1246

8786

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

2.9

20.2

128

419

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.5

19.9

667

4172

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.7

19.4

452

2576

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.2

19.3

208

901

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

19.2

2074

15887

N07AA06

ATC

+∞

19.2

F0024, G301

ICD-10 Finland

+∞

19.2

F29

ICD-10 Finland

Unspecified nonorganic psychosis

3.4

19.2

262

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

0.7

19.0

631

8186

A69

ICPC

General and Unspecified, Other reason for encounter NEC

2.1

18.3

208

923

E000001

ATC

1.4

18.2

1076

7516

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

0.6

18.2

395

5562

G04BD08

ATC

solifenacin; oral

1.6

17.5

517

3133

Z51.88

ICD-10 Finland

Other specified medical care

2.4

17.5

147

566

F0024, G308

ICD-10 Finland

+∞

17.2

3310A

ICD-9 Finland

Other cerebral degenerations, Alzheimer's disease

+∞

17.2

LAITO

NOMESCO Finland

16.7

17.0

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.6

16.7

436

2564

U13

ICPC

Bladder symptom/complaint other

2.0

16.6

210

977

N28

ICPC

Limited function/disability (N)

2.5

16.6

130

483

Z28

ICPC

Limited function/disability (Z)

4.4

16.5

127

J01MA02

ATC

ciprofloxacin; systemic

1.2

16.4

2553

20365

WX402

NOMESCO Finland

General anaesthesia

0.6

16.4

264

3969

N30.9

ICD-10 Finland

Cystitis, unspecified

1.7

16.4

370

2094

Z13.3

ICD-10 Finland

Special screening examination for mental and behavioural disorders

13.7

16.3

SPAT1058

SPAT

PEF monitoring instruction

0.5

16.0

170

2845

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

1.7

16.0

312

1689

S72.1

ICD-10 Finland

Pertrochanteric fracture

1.9

15.9

245

1229

R33

ICD-10 Finland

Retention of urine

1.4

15.8

778

5255

UGC12

NOMESCO Finland

Flexible bronchoscopy

0.6

15.6

288

4204

SPAT1167

SPAT

Insertion of urinary catheter

1.7

15.5

316

1736

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.4

15.4

750

5054

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

4.5

15.2

112

F0019, G309

ICD-10 Finland

+∞

15.2

AAA20

NOMESCO Finland

Insertion of intraventricular pressure monitoring device

6.8

15.1

ZXD35

NOMESCO Finland

Usual procedure

1.9

15.0

212

1031

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.5

14.9

594

3847

N17

ICPC

Vertigo/dizziness

1.4

14.9

743

5033

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.4

14.6

121

466

N06AX21

ATC

duloxetine; oral

1.6

14.4

391

2321

4289X

ICD-9 Finland

Heart failure, unspecified

0.1

14.3

418

M04AA01

ATC

allopurinol; systemic

0.7

14.3

698

8528

N06AX16

ATC

venlafaxine; oral

1.6

14.0

375

2221

AA5DR

NOMESCO Finland

Brain metabolism PET with CT

19.5

14.0

G31.0

ICD-10 Finland

Circumscribed brain atrophy

4.2

14.0

118

A23

ICPC

Risk factor NOS

1.8

13.9

223

1135

WX212

NOMESCO Finland

Femoral plexus blockade

2.1

13.9

156

693

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.1

13.9

165

751

R23.8

ICD-10 Finland

Other and unspecified skin changes

0.7

13.8

480

6200

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

0.4

13.8

1082

R11

ICD-10 Finland

Nausea and vomiting

1.5

13.7

471

2955

WZC30

NOMESCO Finland

Teaching

0.6

13.7

305

4279

A01

ICPC

Pain general/multiple sites

1.5

13.6

438

2713

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

13.5

1535

11738

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.9

13.5

198

978

Z51.5

ICD-10 Finland

Palliative care

1.5

13.4

477

3019

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.3

13.4

1169

8639

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

0.3

13.3

742

S01

ICD-10 Finland

Open wound of head

2.7

13.1

302

H02AB06

ATC

prednisolone; systemic

0.8

13.1

2266

23889

F22.0

ICD-10 Finland

Delusional disorder

2.6

13.0

330

G31.1

ICD-10 Finland

Senile degeneration of brain, not elsewhere classified

7.5

12.9

S01.1

ICD-10 Finland

Open wound of eyelid and periocular area

2.1

12.9

148

665

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

0.7

12.8

352

4740

K59.0

ICD-10 Finland

Constipation

1.5

12.8

417

2587

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

1.8

12.8

205

1045

R2110

NOMESCO Finland

Giving the first information

1.7

12.8

281

1579

XF606

NOMESCO Finland

Ortostatic test

3.0

12.7

226

A04AA01

ATC

ondansetron; systemic, rectal

0.5

12.7

110

1945

R32

ICD-10 Finland

Unspecified urinary incontinence

1.9

12.5

193

973

SAD02

NOMESCO Finland

Assessment of need for oral health care, extensive

2.3

12.4

114

462

S01.8

ICD-10 Finland

Open wound of other parts of head

2.6

12.4

324

S00.0

ICD-10 Finland

Superficial injury of scalp

2.1

12.3

143

647

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

4.2

12.1

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

12.1

2549

20800

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

11.9

822

5867

JN4AD

NOMESCO Finland

Body CT examination

0.6

11.9

195

2921

R03AC02

ATC

salbutamol; inhalant

0.8

11.8

2084

21990

ZXA00

NOMESCO Finland

Right side

1.2

11.7

1774

13986

F05.0

ICD-10 Finland

Delirium not superimposed on dementia, so described

4.4

11.6

EBA15

NOMESCO Finland

Extraction of large number of teeth

1.8

11.6

199

1039

SPAT1284

SPAT

Extensive health certificate

2.0

11.6

139

638

G31.8

ICD-10 Finland

Other specified degenerative diseases of nervous system

3.6

11.6

131

Z20.8

ICD-10 Finland

Contact with and exposure to other communicable diseases

2.1

11.5

133

599

L08

ICPC

Shoulder symptom/complaint

0.7

11.5

557

6832

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

11.4

586

3983

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.6

11.3

291

1707

NFJ54

NOMESCO Finland

Internal fixation of fracture of upper femur with intramedullary nail

1.9

11.3

157

760

P04

ICPC

Feeling/behaving irritable/angry

6.7

11.2

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

0.4

11.2

950

N03AX14

ATC

levetiracetam; systemic

2.1

11.1

126

565

F0021, G301

ICD-10 Finland

+∞

11.1

D07AA02

ATC

hydrocortisone; topical

1.4

11.0

627

4338

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.3

11.0

1137

8569

Z73.6

ICD-10 Finland

Limitation of activities due to disability

2.8

11.0

228

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

0.6

11.0

139

2217

L01BC06

ATC

capecitabine; oral

0.4

11.0

1024

J96.1

ICD-10 Finland

Chronic respiratory failure

0.5

10.9

1258

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.5

10.9

386

2442

S28

ICPC

Limited function/disability (S)

3.4

10.9

143

WF049

NOMESCO Finland

Radiotherapy of metastasis

0.4

10.8

1119

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.3

10.8

928

6826

SPAT1231

SPAT

Assessment of adjustments needed in living environment

1.8

10.8

181

940

D12

ICPC

Constipation

1.7

10.8

235

1320

SPAT1279

SPAT

Preparation of immediate hospitalisation

2.2

10.8

106

447

C03DA01

ATC

spironolactone; oral

0.7

10.8

510

6274

WW500

NOMESCO Finland

Blood transfusion

0.5

10.7

1503

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.5

10.7

1325

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

0.2

10.6

490

F05.8

ICD-10 Finland

Other delirium

2.8

10.6

229

P29

ICPC

Psychological sympt/compl other

2.1

10.6

124

563

G46.8*I67.9

ICD-10 Finland

Other vascular syndromes of brain in cerebrovascular diseases

5.9

10.6

EBA00

NOMESCO Finland

Extraction of tooth

1.2

10.5

1379

10684

W06

ICD-10 Finland

Fall involving bed

2.6

10.5

262

Z60.8

ICD-10 Finland

Other problems related to social environment

4.4

10.5

L82

ICD-10 Finland

Seborrhoeic keratosis

0.7

10.5

503

6179

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

0.1

10.4

388

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

0.5

10.4

1630

201

Kela drug reimbursment

Chronic cardiac insufficiency

0.7

10.3

284

3821

Y94.0

ICD-10 Finland

Accident at home

2.0

10.2

126

586

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

0.8

10.2

852

9734

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

5.0

10.2

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

0.5

10.2

1668

AA1AD

SPAT

5.8

10.2

SPAT1307

SPAT

Psychosocial counselling and guidance

2.0

10.2

121

556

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

10.1

1131

8601

Z03

ICPC

Housing/neighbourhood problem

3.3

10.1

137

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

10.1

508

3443

J01CA04

ATC

amoxicillin; systemic

1.2

10.0

4181

36022

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.3

9.9

367

Z46.9

ICD-10 Finland

Fitting and adjustment of unspecified device

2.1

9.9

103

448

K08.3

ICD-10 Finland

Retained dental root

1.5

9.9

347

2195

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

0.5

9.8

1402

A27

ICPC

Fear of other disease NOS

1.6

9.8

256

1508

C04AE01

ATC

ergoloid mesylates; systemic

2.4

9.8

326

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.5

9.8

326

2034

EBA30

NOMESCO Finland

Excision of root of tooth

1.6

9.8

284

1718

4148X

ICD-9 Finland

Other forms of chronic ischaemic heart disease, Other specified forms of chronic ischaemic heart disease[MORBUS CORDIS ISCHAEMICUS ALIA,MÄÄRITTELEMÄT]

0.3

9.8

604

R06.0

ICD-10 Finland

Dyspnoea

0.8

9.8

1232

13472

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

1.5

9.8

306

1886

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.6

9.7

283

1712

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

0.2

9.7

447

TK800

NOMESCO Finland

Hemodialysis

0.3

9.7

596

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.6

9.7

270

1620

SPAT1050

SPAT

Extensive neurological examination

1.9

9.7

144

720

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.8

9.6

172

911

A10AE05

ATC

insulin detemir; parenteral

1.5

9.6

285

1732

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.8

9.6

148

748

P05

ICPC

Senility, feeling/behaving old

2.8

9.6

205

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

0.2

9.6

442

ZXD05

NOMESCO Finland

Urgent procedure

1.2

9.4

1793

14411

G91.0

ICD-10 Finland

Communicating hydrocephalus

3.5

9.4

111

R03BB01

ATC

ipratropium bromide; inhalant

0.7

9.4

238

3248

L75

ICPC

Fracture: femur

2.0

9.3

112

516

F00.0

ICD-10 Finland

Dementia in Alzheimer disease with early onset

50.9

9.3

XX3DW

NOMESCO Finland

Time consuming IT work

0.7

9.3

252

3400

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

0.4

9.3

894

A10AE04

ATC

insulin glargine; parenteral

1.4

9.2

518

3575

N27

ICPC

Fear of neurological disease other

2.1

9.2

412

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

0.5

9.1

1074

R03DA04

ATC

theophylline; systemic, rectal

0.7

9.1

325

4182

CA1TM

NOMESCO Finland

Calculation of intraocular lens power

0.4

9.1

744

F0001, G300

ICD-10 Finland

+∞

9.1

A10BK03

ATC

empagliflozin; oral

0.6

9.1

100

1650

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.8

9.1

190

H02AA02

ATC

fludrocortisone; oral

2.3

9.0

311

I50.1

ICD-10 Finland

Left ventricular failure

0.7

9.0

241

3261

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

0.7

8.9

237

3207

F22.9

ICD-10 Finland

Persistent delusional disorder, unspecified

3.6

8.9

F00.24

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms of mixed type

11.4

8.9

S22.3

ICD-10 Finland

Fracture of rib

1.4

8.9

359

2337

Z49.1

ICD-10 Finland

Extracorporeal dialysis

0.2

8.9

388

S32.8

ICD-10 Finland

Fracture of other and unspecified parts of lumbar spine and pelvis

2.2

8.9

357

T03

ICPC

Loss of appetite

4.4

8.8

Z11

ICPC

Compliance/being ill problem

3.0

8.8

147

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

0.6

8.8

158

2318

Z75.0

ICD-10 Finland

Medical services not available in home

4.1

8.8

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

8.8

2702

22611

F32

ICD-10 Finland

Depressive episode

1.8

8.8

137

698

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.3

8.8

615

4394

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

0.6

8.8

158

2313

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

0.4

8.7

686

4402A

ICD-9 Finland

Atherosclerosis, Of native arteries of the extremities

0.4

8.7

952

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.3

8.7

671

4866

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.3

8.7

886

6659

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

3.2

8.6

124

A05

ICPC

Feeling ill

1.6

8.6

190

1077

N29

ICPC

Neurological sympt/complt other

2.0

8.5

110

522

I95.9

ICD-10 Finland

Hypotension, unspecified

2.0

8.4

105

493

M02AA07

ATC

piroxicam; topical

1.2

8.4

2226

18391

RD211

NOMESCO Finland

0.5

8.4

1174

N05AB03

ATC

perphenazine; systemic, rectal

1.8

8.4

135

694

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.2

8.4

1825

14828

ZXY02

NOMESCO Finland

Neuropsychologist

5.6

8.3

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.1

8.3

395

S20.2

ICD-10 Finland

Contusion of thorax

1.5

8.3

236

1426

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

2.1

8.2

421

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

0.8

8.2

1054

11526

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.5

8.2

246

1505

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.4

8.2

443

3041

N02AX02

ATC

tramadol; systemic, rectal

0.9

8.1

2023

20906

Z74.1

ICD-10 Finland

Need for assistance with personal care

10.7

8.1

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

3.4

8.1

105

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.8

8.1

133

691

F0022, G301

ICD-10 Finland

+∞

8.1

F0004, G300

ICD-10 Finland

+∞

8.1

F009, G308

ICD-10 Finland

+∞

8.1

F0023, G308

ICD-10 Finland

+∞

8.1

F0009, G309

ICD-10 Finland

+∞

8.1

HMAK

NOMESCO Finland

0.7

8.1

205

2799

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

0.2

8.0

381

NFB40

NOMESCO Finland

Primary total prosthetic replacement of hip joint using hybrid technique

0.6

8.0

114

1761

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

0.4

8.0

676

R63.4

ICD-10 Finland

Abnormal weight loss

1.6

8.0

208

1230

G04CA01

ATC

alfuzosin; oral

1.3

8.0

833

6277

F00.21

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly paranoidism

11.8

8.0

R45.5

ICD-10 Finland

Hostility

11.8

8.0

Z2221

NOMESCO Finland

Medical doctor

1.2

7.9

1437

11473

G04BD07

ATC

tolterodine; oral

1.4

7.9

387

2611

L15

ICPC

Knee symptom/complaint

0.8

7.9

670

7652

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

0.2

7.9

305

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

2.1

7.9

372

WF002

NOMESCO Finland

Radical radiotherapy

0.6

7.9

107

1669

XCH00

NOMESCO Finland

Eye pressure measurement

0.6

7.9

105

1646

K59.09

ICD-10 Finland

Constipation, unspecified

1.4

7.9

397

2694

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

0.4

7.9

798

SPAT1111

SPAT

Planning of analgesia

2.2

7.8

304

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.3

7.8

525

3730

HA1RA

SPAT

0.1

7.8

279

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.3

7.8

625

4554

A11CC03

ATC

alfacalcidol; systemic

0.4

7.8

806

S18

ICPC

Laceration/cut

0.9

7.8

1906

19733

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

1.8

7.7

122

624

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

1.9

7.7

104

504

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

1.8

7.7

135

717

AA1AA

NOMESCO Finland

Head X-ray examination

2.4

7.7

228

D70.82

ICD-10 Finland

Drug-induced neutropenia

0.2

7.7

353

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

0.3

7.6

472

L90

ICPC

Osteoarthrosis of knee

0.7

7.6

170

2380

WF003

NOMESCO Finland

Adjuvant radiotherapy

0.5

7.6

945

XA400

NOMESCO Finland

EEG

3.2

7.6

111

JN4BD

NOMESCO Finland

Extensive body CT

0.7

7.6

392

4765

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.3

7.5

780

5869

S15

ICPC

Foreign body in skin

0.6

7.5

131

1931

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

2.5

7.5

198

A12AA04

ATC

calcium carbonate; oral

0.3

7.5

543

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.4

7.5

437

3036

N05CD07

ATC

temazepam; oral

1.2

7.5

1015

7871

WX199

NOMESCO Finland

Other local analgesia

0.5

7.5

943

Y94.1

ICD-10 Finland

Accident in connection with service housing

5.8

7.5

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.3

7.4

603

4397

R1250

SPAT

3.1

7.4

113

T05

ICPC

Feeding problem of adult

3.2

7.4

103

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

0.7

7.4

278

3545

R45.1

ICD-10 Finland

Restlessness and agitation

5.1

7.4

JAB30

NOMESCO Finland

Repair of inguinal hernia using prosthetic material

1.3

7.4

707

5268

R54

ICD-10 Finland

Senility

2.5

7.4

195

P28

ICPC

Limited function/disability (P)

3.4

7.3

SPAT1236

SPAT

Informing family of child’s disability

1.8

7.3

124

649

WYA30

SPAT

3.7

7.3

N02AC04

ATC

dextropropoxyphene; oral

0.7

7.3

176

2425

S82

ICPC

Naevus/mole

0.7

7.3

310

3876

H25.1

ICD-10 Finland

Senile nuclear cataract

1.2

7.3

2571

21660

SPAT1263

SPAT

Sampling

1.2

7.3

2285

19084

F34.1

ICD-10 Finland

Dysthymia

2.0

7.3

377

SPAT1104

SPAT

Monitoring of emergency patient

1.4

7.2

377

2576

F00, F03

ICD-10 Finland

5.9

7.2

SPAT1157

SPAT

Guidance concerning treatment of mouth and mucous membranes

2.0

7.2

369

N05CF01

ATC

zopiclone; oral

1.2

7.2

2208

18407

N05AX12

ATC

aripiprazole; systemic

2.9

7.1

130

T08

ICPC

Weight loss

2.1

7.1

361

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

1.7

7.1

135

733

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.2

7.1

875

6717

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

0.5

7.1

1173

F0021, G308

ICD-10 Finland

+∞

7.1

F0022, G308

ICD-10 Finland

+∞

7.1

F0010, G308

ICD-10 Finland

+∞

7.1

S32.5

ICD-10 Finland

Fracture of pubis

2.1

7.0

314

AA1CG

SPAT

3.8

7.0

N18.8

ICD-10 Finland

Other chronic renal failure

0.6

7.0

1328

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

0.6

7.0

127

1850

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

0.7

7.0

152

2135

R07.4

ICD-10 Finland

Chest pain, unspecified

1.2

7.0

1567

12740

IAB14

NOMESCO Finland

Geriatric psychiatry consultation

4.1

6.9

SPAT1125

SPAT

Stoma care and guidance

1.7

6.9

128

692

K02.1

ICD-10 Finland

Caries of dentine

1.2

6.9

1966

16278

L03AA02

ATC

filgrastim; parenteral

0.4

6.9

703

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

0.3

6.9

380

F00.04

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms of mixed type

27.8

6.9

ZYB04

NOMESCO Finland

Outreach service in patient’s home or everyday environment

4.9

6.8

F00.23

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly depression

18.5

6.8

C01AA05

ATC

digoxin; systemic

0.8

6.8

689

7730

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

4.1

6.8

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

0.2

6.8

276

R06AE07

ATC

cetirizine; oral

1.2

6.8

1766

14520

R35

ICD-10 Finland

Polyuria

1.4

6.8

390

2710

P99

ICPC

Psychological disorders other

2.5

6.8

182

TNC33

NOMESCO Finland

Custom moulded brace, elbow or forearm

4.5

6.7

4912A

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]

0.3

6.7

392

I67.4

ICD-10 Finland

Hypertensive encephalopathy

7.3

6.7

F009, F03

ICD-10 Finland

8.1

6.7

TPX10

NOMESCO Finland

Implantation of vascular injection port

0.5

6.6

746

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

0.3

6.6

360

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

0.7

6.6

200

2643

DFF00

NOMESCO Finland

Pure tone audiometry

0.7

6.6

295

3659

K86

ICPC

Hypertension uncomplicated

0.8

6.6

487

5655

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

0.2

6.6

339

A04AA55

ATC

palonosetron, combinations; systemic

0.2

6.6

307

G04BD10

ATC

darifenacin; oral

2.3

6.5

215

PJA12

NOMESCO Finland

Sentinel node biopsy

0.7

6.5

147

2047

SPAT1014

SPAT

Treatment of eyes

1.7

6.5

117

629

XQ848

NOMESCO Finland

Dermatological photography

0.5

6.5

859

N05BE01

ATC

buspirone; oral

1.9

6.5

471

Z51.0

ICD-10 Finland

Radiotherapy session

0.3

6.5

431

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

0.7

6.5

139

1953

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.3

6.4

374

2602

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

1.7

6.4

123

673

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

3.6

6.4

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.7

6.4

137

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

2.9

6.4

119

D07BC01

ATC

betamethasone and antiseptics; topical

1.3

6.4

592

4395

L03AA14

ATC

lipegfilgrastim; parenteral

0.2

6.4

281

S52.5

ICD-10 Finland

Fracture of lower end of radius

1.3

6.4

469

3377

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

0.3

6.4

411

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

3.7

6.3

N03AF02

ATC

oxcarbazepine; oral

1.7

6.3

127

703

4273A

ICD-9 Finland

Cardiac dysrhythmias, Atrial fibrillation and flutter

0.6

6.3

112

1641

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

0.4

6.3

558

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

0.8

6.3

427

5007

Z00.6

ICD-10 Finland

Examination for normal comparison and control in clinical research programme

3.7

6.3

S01BC05

ATC

ketorolac; ophthalmic

1.3

6.3

370

2580

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

2.9

6.3

107

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

0.5

6.2

743

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.3

6.2

464

3351

ZXA05

NOMESCO Finland

Left side

1.2

6.2

1622

13325

E53.8

ICD-10 Finland

Deficiency of other specified B group vitamins

2.5

6.2

177

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.2

6.2

262

4120X

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,MÄÄRITTELEMÄT]

0.6

6.2

1200

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.8

6.1

486

ZX120

NOMESCO Finland

Intravenous

0.7

6.1

308

3757

T90.5

ICD-10 Finland

Sequelae of intracranial injury

2.4

6.1

179

Z01.7

ICD-10 Finland

Laboratory examination

1.3

6.1

497

3629

SPAT1043

SPAT

Audiometry

0.8

6.1

476

5490

207

Kela drug reimbursment

Chronic arrhythmias

0.8

6.1

949

10220

F0029, G301

ICD-10 Finland

+∞

6.1

-1

ICD-10 Finland

1.9

6.1

370

F06.9

ICD-10 Finland

Unspecified mental disorder due to brain damage and dysfunction and to physical disease

3.9

6.0

SPAT1059

SPAT

Spirometry at the office

0.6

6.0

125

1771

N99

ICPC

Neurological disease other

2.1

6.0

279

R03BA08

ATC

ciclesonide; inhalant

0.7

6.0

149

2038

H02BX01

ATC

methylprednisolone, combinations; systemic

1.3

6.0

352

2454

IBZ07

NOMESCO Finland

Neurological assessment in psychiatry

6.8

6.0

S72.9

ICD-10 Finland

Fracture of femur, part unspecified

2.5

6.0

165

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.4

6.0

292

1975

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.1

6.0

2103

17646

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.4

6.0

270

1801

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

378

233

14.43

307.65

1.0

ng/l

57.1

39.0

6.01

271

129

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

375

233

14.32

307.65

1.0

ng/l

430.4

297.2

7.15

271

131

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

378

233

14.43

307.65

1.0

ng/l

538.2

693.0

5.96

264

127

(3019309) Folate [Moles/volume] in Red Blood Cells

3545

17045

2.25

284.29

1.9

1.8

nmol/l

1205.1

1160.1

1.86

2469

12533

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2600

13842

1.84

135.26

3.2

3.0

mmol/l

2.5

7.80

2237

11740

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

387

887

3.85

120.01

1.2

1.3

mg/l

476.6

630.8

3.43

337

840

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

342

751

4.01

112.42

1.3

1.4

e6/l

194.6

1144.8

2.79

266

632

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

342

751

4.01

112.42

1.2

1.3

e6/l

7.2

24.2

1.21

261

601

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

340

778

3.85

105.59

1.1

1.2

mmol/l

3.8

3.9

1.14

310

714

(3015377) Calcium [Moles/volume] in Serum or Plasma

3629

22441

1.62

103.42

2.6

3.1

mmol/l

2.4

0.02

3007

18584

(3044290) Cell count panel - Cerebral spinal fluid

312

694

3.95

100.73

1.2

1.3

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

264

555

4.16

91.88

3.0

3.4

umol/l

303.5

321.0

0.98

209

442

(3023410) Appearance of Cerebral spinal fluid

179

299

5.21

82.00

1.3

1.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1543

20473

0.58

81.26

3.1

3.8

mg/mmol

12.0

10.5

0.44

908

12848

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

784

12451

0.50

74.97

1.4

1.6

mmol/l

1.2

3.35

670

10074

(3031040) Bacteria [#/volume] in Urine by Automated count

5753

41318

1.49

72.40

6.2

5.8

e6/l

3192.4

1596.3

1.10

181

729

(3009508) Creatinine [Moles/volume] in Urine

1459

19148

0.59

71.60

2.4

3.1

mmol/l

7.1

6.5

4.74

1097

15356

(3012516) Albumin [Mass/volume] in Urine

1462

19157

0.59

71.21

2.5

3.1

mg/l

545.0

377.1

0.61

875

12210

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

4298

29513

1.45

65.12

2.5

2.2

pmol/l

90.0

92.2

2.29

2161

15138

(40768804) Tissue Pathology biopsy report

1832

21864

0.65

56.31

2.2

2.4

—

(3003338) MCHC [Mass/volume]

5330

39148

1.38

48.69

26.6

27.6

g/l

329.2

329.7

2.89

5143

38529

(3024561) Albumin [Mass/volume] in Serum or Plasma

4154

29317

1.38

48.41

3.6

4.3

g/l

34.1

33.7

3.82

3651

26585

(3026008) Bacteria identified in Urine by Culture

3527

24384

1.38

45.82

3.8

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4818

47441

0.74

44.65

3.7

4.7

mmol/l

1.4

0.71

3999

41360

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1507

9017

1.51

42.45

1.9

1.8

—

(3023368) Bacteria identified in Blood by Culture

3144

21561

1.37

41.90

4.0

4.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4931

48067

0.75

40.15

3.7

4.8

mmol/l

4.3

1.55

4105

42332

(3019150) Specific gravity of Urine by Refractometry

2013

12872

1.43

40.12

5.5

5.2

kg/l

1.0

0.92

310

2231

(3016018) Differential panel - Cerebral spinal fluid

142

355

3.46

38.86

1.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4683

45884

0.75

38.78

3.3

4.2

mmol/l

1.2

1.88

3816

39490

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1492

9073

1.49

38.49

1.9

1.8

—

(3021960) Folate [Moles/volume] in Serum or Plasma

2686

18294

1.36

36.12

1.7

1.6

nmol/l

20.4

20.1

0.36

2373

15295

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3044

21213

1.34

34.91

2.5

2.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

839

4611

1.61

33.93

1.5

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1991

13162

1.37

31.58

1.9

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

457

6694

0.56

30.77

1.2

u/ml

13.1

16.0

0.28

114

2131

(1761868) Lipid panel - Serum or Plasma

922

11434

0.66

30.76

3.0

3.7

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

6695

52518

1.31

30.01

20.2

mg/l

33.2

28.9

15.87

5752

44639

(3002179) Metamyelocytes/100 leukocytes in Blood

268

4580

0.49

29.85

2.9

3.4

0.7

0.6

0.09

1098

(3021440) Promyelocytes/100 leukocytes in Blood

298

4880

0.51

29.15

3.1

3.5

0.2

0.1

0.57

1492

(3017181) Myelocytes/100 leukocytes in Blood

320

5113

0.52

28.95

3.0

3.5

1.0

0.9

0.09

100

1590

(3026493) Urate [Moles/volume] in Serum or Plasma

1390

15808

0.71

28.74

2.3

2.9

umol/l

9792.3

7686.5

0.59

1068

12985

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2273

15567

1.33

28.08

1.8

pmol/l

443.8

17014897.3

5.83

1763

12172

(3011397) Hemoglobin [Presence] in Urine by Test strip

2063

13930

1.34

28.06

4.6

4.4

—

(40761535) Cells panel - Urine sediment

970

5749

1.50

27.78

4.0

3.8

—

(3025159) Blasts/100 leukocytes in Blood

276

4488

0.51

26.34

3.1

3.5

0.0

0.4

2.20

1224

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3285

23859

1.27

25.54

2.0

2.2

nmol/l

78.3

80.9

4.58

2735

20204

(4035726)

342

5156

0.55

25.34

1.2

1.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

5305

49907

0.80

24.37

4.4

5.5

mmol/l

2.4

1.20

4491

43771

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

539

7131

0.63

23.82

1.2

iu/ml

42.3

42.5

0.01

161

2176

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4113

30958

1.24

22.64

4.3

5.7

mmol/l

1.2

3.22

3546

27456

(3022217) INR in Platelet poor plasma by Coagulation assay

1778

12112

1.32

22.02

30.0

34.0

inr

1.7

1.6

1.09

106

1595

(3037522) Nuclear Ab [Titer] in Serum

395

5510

0.60

21.75

1.2

1.3

titre

439.0

513.0

0.49

1334

(3013512) EKG study

1896

19898

0.77

21.48

4.4

4.9

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

380

1927

1.72

20.84

1.4

1.3

—

(3018418) pH of Serum or Plasma

2804

20365

1.26

20.69

2.9

3.9

7.4

0.63

392

3861

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

379

1927

1.71

20.59

1.4

1.3

—

(3015736) pH of Urine

3100

22790

1.25

20.49

4.5

4.3

—

5.9

—

(3029937) Albumin [Presence] in Urine by Test strip

2216

15672

1.28

20.40

5.3

5.0

estimate

0.0

0.80

437

5003

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2704

26925

0.80

18.96

3.8

4.4

—

(40761511) CBC panel - Blood by Automated count

6537

52179

1.24

18.94

18.9

19.8

—

(3010813) Leukocytes [#/volume] in Blood

6889

55347

1.24

18.53

27.7

29.7

e9/l

7.3

7.2

2.70

6466

53003

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

253

3806

0.56

18.50

1.3

—

(3035941) MCH [Entitic mass]

6883

55333

1.24

18.17

27.6

29.5

30.4

0.71

6561

53918

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

467

2585

1.58

18.17

1.2

—

(3026361) Erythrocytes [#/volume] in Blood

6883

55335

1.24

18.15

27.7

29.6

e12/l

4.2

4.3

18.17

6450

52975

(3007461) Platelets [#/volume] in Blood

6882

55327

1.24

18.14

27.7

29.6

e9/l

235.3

235.1

0.10

6487

53259

(3024731) MCV [Entitic volume]

6883

55336

1.24

18.14

27.6

29.5

92.0

92.1

0.61

6563

53922

(3000963) Hemoglobin [Mass/volume] in Blood

6883

55343

1.24

18.08

27.9

29.9

g/l

126.6

128.6

24.51

6550

53946

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3648

27548

1.22

18.02

4.7

4.8

ng/l

56.6

98.4

1.57

2825

22435

(4010399)

260

3850

0.57

17.95

1.3

1.4

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

6852

55107

1.24

17.71

24.0

24.9

mmol/l

4.0

7.43

6500

53311

(3019550) Sodium [Moles/volume] in Serum or Plasma

6847

55067

1.24

17.67

23.9

24.7

mmol/l

139.7

139.3

16.57

6509

53368

(3019832) Treponema pallidum Ab [Presence] in Serum

192

836

1.99

17.17

1.1

1.2

—

(3021589) Normoblasts [#/volume] in Blood

2365

23664

0.81

16.80

8.8

11.0

e9/l

0.0

1.53

1825

19079

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2773

20482

1.23

16.71

2.2

2.1

u/l

254.3

223.5

1.06

2515

18967

(3037467) Urinalysis macro (dipstick) panel - Urine

5208

40896

1.20

16.49

5.1

5.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

623

7429

0.70

16.07

4.1

4.9

34.3

34.6

0.25

325

4646

(3002256) Pathology report gross observation

643

7562

0.71

15.26

1.4

—

(3003694) ABO and Rh group [Type] in Blood

1102

11933

0.76

15.05

1.2

1.3

—

(3022145) Colonoscopy Study observation

448

5604

0.67

14.92

1.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

5465

43307

1.19

14.85

22.9

22.2

36.4

36.5

0.24

2982

23653

(3028026) IgM [Mass/volume] in Serum or Plasma

184

2830

0.55

14.57

1.7

1.8

g/l

1.7

1.5

0.25

140

2476

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

801

5145

1.36

14.38

1.9

1.7

—

(40760892) CBC W Ordered Manual Differential panel - Blood

938

10322

0.75

14.37

3.5

4.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

278

3810

0.61

14.15

1.6

1.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

270

1391

1.68

14.08

1.3

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

689

7907

0.73

14.01

2.5

3.6

ug/l

26.8

25.5

0.05

547

6640

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1180

8052

1.29

13.87

10.3

9.9

—

(3005719) IgG [Mass/volume] in Serum or Plasma

250

3484

0.60

13.65

2.6

g/l

10.9

0.00

204

3117

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

5180

47644

0.85

13.19

19.7

ml/min/173m2

66.2

65.1

3.66

4041

39852

(3022096) Basophils/100 leukocytes in Blood

2623

25530

0.83

13.15

4.4

5.4

0.6

0.97

2319

23250

(3035350) Ketones [Presence] in Urine by Test strip

3685

28434

1.18

12.96

4.7

4.5

estimate

0.0

0.00

485

5383

(3019069) Monocytes/100 leukocytes in Blood

2718

26300

0.84

12.60

4.6

5.7

8.9

9.0

2.13

2409

23959

(3006504) Eosinophils/100 leukocytes in Blood

2704

26172

0.84

12.57

4.3

5.4

2.8

0.31

2394

23801

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

816

8995

0.76

12.55

2.5

3.4

u/l

248.2

251.2

0.24

700

8328

(40768797) Stomach Pathology biopsy report

671

7594

0.74

12.40

1.2

—

(3006315) Basophils [#/volume] in Blood

2881

27687

0.84

12.21

4.2

5.0

e9/l

0.0

1.28

2337

23193

(3020779) Urea [Moles/volume] in Serum or Plasma

591

6793

0.73

12.08

3.6

5.4

mmol/l

11.7

12.7

2.59

531

6280

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

110

449

2.11

11.85

2.5

2.4

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

870

9438

0.77

11.83

3.3

4.7

mmol/l

1.0

2.18

736

8487

(3001604) Monocytes [#/volume] in Blood

2865

27481

0.85

11.73

4.2

5.0

e9/l

0.6

0.45

2324

22972

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

149

2274

0.55

11.54

2.7

3.9

u/ml

199.2

87.5

0.99

138

2152

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

416

2481

1.46

11.46

1.4

1.6

1.7

0.28

331

1943

(3021601) Nitrite [Presence] in Urine by Test strip

3653

28363

1.17

11.45

6.1

6.2

estimate

0.0

0.00

472

5329

(3013115) Eosinophils [#/volume] in Blood

2986

28494

0.85

11.37

4.3

5.2

e9/l

0.2

0.32

2397

24138

(3000492) Spirometry study

267

3509

0.64

11.31

1.5

1.6

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

375

4594

0.69

11.17

3.0

ml/min/173m2

53.8

54.5

0.22

154

2232

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1085

7520

1.27

11.15

2.5

2.6

ug/l

5.4

5.7

0.26

764

6173

(3018010) Neutrophils/100 leukocytes in Blood

2723

26134

0.85

11.04

4.4

5.4

61.4

60.2

5.05

2418

23767

(3002030) Lymphocytes/100 leukocytes in Blood

2787

26675

0.85

10.88

4.6

5.6

23.3

24.3

4.35

2446

24125

(3009261) Glucose [Presence] in Urine by Test strip

3689

28770

1.16

10.68

4.8

4.7

estimate

0.0

0.00

473

5322

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5870

47384

1.16

10.64

4.8

5.0

mu/l

2.0

2.1

5.51

5083

41521

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2612

19872

1.17

10.30

2.3

2.4

mg/l

3.1

3.2

3.47

2089

16635

(3013139) Helicobacter pylori Ag [Presence] in Stool

248

3231

0.65

10.11

1.3

1.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2817

21593

1.17

10.06

5.4

5.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1448

0.49

9.94

1.8

2.6

u/ml

129.8

824.5

2.54

1311

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4353

34506

1.15

9.75

4.7

6.3

mmol/l

1.2

12.66

3500

28512

(3019198) Lymphocytes [#/volume] in Blood

2969

28098

0.86

9.67

4.3

5.2

e9/l

1.7

1.8

1.10

2410

23888

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

142

2048

0.59

9.00

1.6

1.5

titre

100.0

262.5

—

105

(3018095) Leukocytes [#/volume] in Urine

3020

23440

1.15

8.87

4.2

4.1

e6/l

177.1

147.4

0.44

2154

17412

(3013650) Neutrophils [#/volume] in Blood by Automated count

3454

32193

0.87

8.79

5.5

7.7

e9/l

4.8

4.5

6.02

2848

27483

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

136

1956

0.59

8.55

1.4

1.6

u/l

38.2

38.1

0.02

1608

(3013826) Glucose [Moles/volume] in Serum or Plasma

4628

37040

1.14

8.52

4.2

4.7

mmol/l

7.1

7.0

1.82

4327

34817

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2768

26151

0.87

8.49

3.0

3.4

ng/l

2497.1

2297.9

1.03

2269

22855

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1291

0.50

8.47

1.5

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1506

11096

1.19

8.46

3.1

3.3

e6/l

2.7

2.8

0.05

839

6338

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5367

48529

0.88

8.37

6.2

7.1

mmol/mol

42.2

41.7

2.52

4569

43101

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

306

3684

0.70

8.31

1.3

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

267

1564

1.48

8.17

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1055

0.46

8.16

1.2

u/ml

6.3

5.6

—

182

(40768443) Skin Pathology biopsy report

220

2806

0.66

8.15

1.2

—

(42870588) Differential panel, method unspecified - Blood

2074

19956

0.86

8.11

4.0

5.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

183

2.44

8.05

3.0

2.9

umol/l

27.3

29.2

0.76

130

(3005322) IgE [Units/volume] in Serum or Plasma

141

1973

0.61

7.96

1.2

u/ml

323.5

240.0

0.60

122

1774

(3014765) Yersinia sp identified in Stool by Organism specific culture

268

1582

1.46

7.90

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1042

0.47

7.90

1.2

u/ml

1.4

7.9

—

113

(42529406) Shigella sp [Presence] in Stool by Culture

268

1583

1.46

7.88

1.2

—

(3014271) Vancomycin [Susceptibility]

132

664

1.71

7.72

3.5

3.1

—

(36304419) Bacteria [Presence] in Urine

2356

18111

1.15

7.71

3.5

—

(3007164) IgA [Mass/volume] in Serum or Plasma

739

7778

0.80

7.69

1.4

1.5

g/l

2.8

0.18

312

4126

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

217

2732

0.67

7.55

2.4

2.7

—

(3042631) Mycobacterium sp identified in Specimen

1194

0.51

7.51

2.2

2.7

—

(4094501)

1152

0.51

7.36

1.0

1.1

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1047

10579

0.83

7.28

2.2

2.6

19.3

20.3

1.69

790

8796

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1112

11161

0.83

7.18

2.0

2.5

g/l

2.1

2.2

4.71

950

10084

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

5587

50179

0.89

7.13

4.4

5.4

mmol/l

6.2

0.22

4676

43499

(40768793) Breast Pathology biopsy report

1070

0.50

7.10

1.3

—

(3006270) Folate [Moles/volume] in Blood

139

727

1.65

7.07

1.3

1.2

nmol/l

307.8

302.4

0.11

113

522

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

108

2.78

7.05

3.6

3.1

u/field

0.5

0.4

0.08

108

(4034850)

295

1814

1.41

7.02

11.8

14.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

281

1714

1.42

7.00

1.2

—

(3000330) Specific gravity of Urine by Test strip

365

4153

0.74

6.99

4.4

4.5

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

240

2915

0.70

6.91

2.6

2.8

mg/l

54.5

97.0

1.19

194

2372

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

441

0.25

6.75

1.2

1.5

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4805

38864

1.12

6.74

3.7

4.0

pmol/l

15.2

15.3

2.00

4057

33801

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

241

2909

0.70

6.70

2.6

2.8

mg/l

66.3

57.7

0.15

198

2367

(3015171) Extractable nuclear Ab [Units/volume] in Serum

108

1542

0.60

6.69

1.3

1.2

u/ml

0.6

1.0

0.46

167

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1223

0.55

6.61

1.6

mg/l

14.8

13.0

0.80

1099

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

905

0.48

6.58

1.2

u/ml

1.1

7.0

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

375

4210

0.75

6.56

2.5

2.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

923

0.49

6.48

1.1

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

6540

53927

1.13

6.36

22.0

24.1

umol/l

86.4

89.2

8.48

6535

53887

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

803

5731

1.22

6.28

1.5

1.6

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

448

0.29

6.26

1.4

1.5

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

237

2827

0.71

6.18

2.6

2.8

ratio

4.2

2.8

0.38

203

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

131

1748

0.64

6.12

1.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

1258

0.58

6.09

1.3

—

(3023419) Bacteria identified in Sputum by Culture

911

0.51

6.03

1.7

2.3

—

(3004809) Band form neutrophils/100 leukocytes in Blood

1265

0.59

5.84

3.4

3.5

2.5

1.5

0.86

938

(3000494) Fungus identified in Specimen by Culture

549

5790

0.80

5.83

1.3

1.4

—

(3044640) Blood type and Crossmatch panel - Blood

2111

19905

0.88

5.80

2.3

2.6

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

479

0.34

5.76

2.7

3.5

—

(3002582) Erythrocytes [#/volume] in Urine

2663

20961

1.12

5.76

3.6

e6/l

86.0

129.9

1.56

2049

16434

(3017354) Segmented neutrophils/100 leukocytes in Blood

769

0.48

5.73

3.3

3.5

56.3

60.8

0.35

458

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1279

0.59

5.72

1.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

333

3724

0.76

5.70

4.4

7.6

—

(40760888) Immunoglobulin light chains.free panel - Serum

176

2175

0.69

5.65

2.9

2.8

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

728

0.47

5.61

1.5

1.7

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1849

14253

1.14

5.59

4.3

4.5

ng/l

257.0

437.6

1.56

1670

12870

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1144

0.58

5.45

2.6

2.9

—

(40768795) Lymph node Pathology biopsy report

515

0.38

5.43

1.1

1.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1546

11798

1.15

5.42

2.9

3.1

e6/l

1.6

1.4

0.93

872

6964

(3042936) Bacteria identified in Isolate by Culture

925

9183

0.85

5.20

1.8

1.9

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

170

2076

0.70

5.14

1.9

1.6

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

440

1.70

5.14

1.4

1.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1559

14881

0.88

5.12

2.2

2.5

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

104

1398

0.63

5.09

2.1

2.4

mg/l

1.7

1.9

1.72

1206

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

664

0.48

5.03

1.9

2.0

u/ml

117.0

1235.3

1.35

651

(3052592) Norovirus Ag [Presence] in Stool

179

2.11

5.02

1.3

—

(3004616) Nuclear Ab [Presence] in Serum

590

0.45

4.96

1.1

1.3

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1273

0.62

4.95

1.3

1.4

g/l

1.1

0.11

1185

(3022313) Gas panel - Capillary blood

309

3418

0.77

4.92

3.0

3.9

—

(3032080) INR in Blood by Coagulation assay

3271

29884

0.90

4.91

10.8

12.7

inr

1.3

1.4

3.97

734

7931

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

595

6108

0.82

4.89

3.2

3.7

mmol/l

1.2

0.50

455

5250

(3007930) Methemoglobin/Hemoglobin.total in Blood

303

3356

0.77

4.87

3.3

4.3

0.9

1.70

288

3170

(3045414) Leukocytes [Presence] in Urine

219

2539

0.73

4.86

2.3

2.1

—

(3048689) Calprotectin [Mass/mass] in Stool

432

4576

0.80

4.81

1.7

1.8

ug/g

168.2

178.5

0.25

313

3408

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1094

0.60

4.80

1.2

1.3

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

101

1344

0.64

4.75

2.0

2.1

g/l

3.7

3.6

0.25

1259

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

907

0.56

4.74

1.2

1.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

1037

0.59

4.74

1.1

titre

74.3

91.1

—

(3009343) pH of Capillary blood

463

4857

0.81

4.72

2.8

3.7

7.4

2.27

637

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

624

0.48

4.70

1.2

1.3

—

(3045142) Bone marrow Pathology biopsy report

670

0.50

4.70

1.2

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

470

4916

0.81

4.66

2.8

3.7

kpa

5.2

0.10

408

4445

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1242

0.63

4.63

1.9

89.8

86.7

0.73

1172

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1241

0.63

4.62

1.3

g/l

0.2

0.06

1155

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1271

12217

0.87

4.61

3.0

3.4

ug/l

0.9

0.26

906

9018

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1165

0.62

4.58

2.8

2.1

208.0

217.4

0.47

1089

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

377

2577

1.26

4.46

1.8

2.1

ug/l

1315.5

553.3

0.72

345

2438

(3020630) Protein [Mass/volume] in Serum or Plasma

685

6879

0.84

4.43

2.0

2.3

g/l

65.2

65.6

0.62

543

6007

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

311

3388

0.78

4.43

3.4

4.2

1.6

1.5

0.75

295

3205

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

812

0.56

4.43

2.8

3.2

iu/ml

216.8

3994.4

—

113

(3005988) Vibrio sp identified in Specimen by Organism specific culture

831

0.56

4.37

1.1

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

828

0.57

4.32

1.1

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

893

0.58

4.32

1.2

1.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

906

8876

0.86

4.30

1.2

u/ml

1.3

1.7

0.56

184

2054

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

999

0.61

4.30

1.2

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

847

0.57

4.27

1.1

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

825

0.57

4.27

1.1

1.3

—

(40768800) Prostate Pathology biopsy report

102

1318

0.66

4.23

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

171

2012

0.72

4.22

1.1

iu/ml

65.3

122.4

1.56

639

(3045424) Erythrocytes [Presence] in Urine

896

0.59

4.19

1.6

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

828

0.58

4.14

1.1

1.3

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1256

11993

0.88

4.09

2.0

2.5

umol/l

10.5

11.2

3.06

1067

10823

(40757373) Influenza virus identified in Isolate

159

2.05

4.09

1.3

—

(3043409) Potassium [Moles/volume] in Arterial blood

346

2369

1.26

4.07

2.7

3.9

mmol/l

3.9

0.18

309

2194

(1761482) Bacteria [#/volume] in Urine by Culture

235

2623

0.76

4.07

5.1

5.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

570

5771

0.84

4.07

2.1

2.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

833

0.58

4.04

1.1

1.3

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

172

2.00

4.01

2.8

2.0

umol/l

63.7

55.7

0.68

121

(21494890) Protein electrophoresis panel - 24 hour Urine

818

0.58

3.97

1.7

1.8

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

816

0.59

3.93

4.8

3.7

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

456

4693

0.82

3.89

2.8

3.7

mmol/l

2.2

2.1

0.13

325

3406

(4281824)

559

0.50

3.88

1.1

1.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

119

1465

0.69

3.87

1.3

1.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

128

1554

0.70

3.85

1.3

1.4

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

341

0.38

3.78

1.1

1.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

341

0.38

3.78

1.1

1.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

341

0.38

3.78

1.1

1.3

—

(3017732) Neutrophils [#/volume] in Blood

328

3479

0.80

3.76

3.1

3.3

e9/l

4.4

0.03

191

2259

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

153

1794

0.73

3.74

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

540

0.51

3.74

1.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

720

5341

1.17

3.73

2.2

2.4

u/l

32.8

37.4

1.50

587

4485

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

1159

0.66

3.72

1.2

u/l

38.4

42.1

0.13

983

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

560

0.52

3.69

1.2

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

560

0.52

3.69

1.2

1.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

560

0.52

3.69

1.2

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

757

0.59

3.67

1.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

423

4351

0.83

3.61

2.6

3.4

mmol/l

25.2

25.1

0.44

408

4232

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

598

0.54

3.56

1.2

1.3

nmol/l

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

2.86

3.50

2.5

2.6

nmol/l

142.7

138.9

0.06

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

264

0.32

3.48

1.0

1.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

264

0.32

3.48

1.0

1.4

—

(44806420)

338

0.40

3.44

2.1

2.5

—

(3023183) Ammonium ion [Moles/volume] in Plasma

181

1166

1.34

3.44

1.5

1.8

umol/l

24.8

32.1

7.07

136

903

(3008898) HLA-B27 [Presence]

613

0.56

3.44

1.0

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

232

2529

0.78

3.40

2.0

2.8

u/ml

469.4

3095.1

1.54

173

2130

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

384

0.45

3.40

1.3

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

317

3334

0.81

3.40

1.3

1.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

242

2618

0.79

3.34

1.8

1.9

nmol/l

9.4

9.8

0.30

195

2140

(3037692) Legionella sp identified in Specimen by Organism specific culture

194

0.31

3.34

1.0

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

194

0.31

3.34

1.0

1.1

—

(3011985) Renin [Units/volume] in Plasma

618

0.57

3.33

1.2

1.3

mu/l

34.9

54.6

0.65

530

(3014891) Appearance of Pleural fluid

185

1.86

3.31

1.4

1.5

—

(3028626) Oxygen [Partial pressure] in Capillary blood

171

1928

0.76

3.26

2.4

2.9

kpa

7.4

7.6

0.75

164

1777

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

116

1386

0.71

3.24

1.2

1.3

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

492

4939

0.85

3.23

2.4

3.2

g/l

126.6

124.6

1.31

480

4821

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

340

0.43

3.23

1.1

1.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

444

0.50

3.20

1.1

1.3

u/l

18.3

13.2

0.77

338

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

175

1.86

3.20

1.3

1.4

umol/l

102.1

83.8

0.27

100

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1666

15452

0.91

3.18

2.5

2.9

u/l

36.3

36.5

0.03

1503

14381

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

714

0.61

3.14

1.2

u/ml

100.4

42.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

529

0.55

3.11

1.0

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1153

0.70

3.08

1.3

1.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

200

0.34

3.06

1.9

2.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

834

0.64

3.04

1.2

1.1

—

(3030467) Casts [#/volume] in Urine by Automated count

2381

19150

1.09

3.04

3.5

e6/l

0.6

0.16

1833

14854

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

180

1993

0.77

3.03

1.6

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

1119

0.69

3.03

2.7

3.2

61.2

60.4

0.22

1119

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

800

0.64

3.00

1.4

75.1

64.5

1.82

514

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

268

0.38

2.98

1.2

1.4

—

(3006462) Nitrate [Presence] in Urine

339

0.45

2.95

3.4

4.5

—

(4015189)

207

0.37

2.94

1.3

2.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

573

0.58

2.93

1.1

1.2

pmol/l

228.0

257.5

0.46

432

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

268

2819

0.81

2.93

3.2

4.2

mmol/l

25.1

24.9

0.54

218

2493

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

395

0.50

2.92

1.2

mmol/l

6.5

8.3

2.37

246

(40768441) Liver Pathology biopsy report

301

0.43

2.91

1.0

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

592

0.59

2.88

1.5

g/l

0.7

0.8

0.44

446

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

505

0.56

2.88

1.1

iu/ml

154.1

583.5

—

(3023520) Reticulocytes [#/volume] in Blood

772

7430

0.88

2.87

2.2

2.3

e9/l

65.3

66.3

0.36

565

5685

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1304

12172

0.90

2.82

1.6

1.7

mg/l

1.9

1.7

1.08

993

9565

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

992

0.69

2.81

1.2

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

165

0.31

2.81

1.0

1.8

—

6007.5

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

880

0.67

2.81

3.0

3.5

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

177

0.34

2.81

1.3

2.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

934

7201

1.12

2.80

4.4

4.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

268

1.63

2.78

1.0

1.1

—

(3047189) Immunofixation for 24 hour Urine

353

0.48

2.77

1.1

1.4

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

627

0.61

2.76

1.1

1.2

—

18.9

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

647

0.62

2.74

1.1

—

(3011412) CD3 cells [#/volume] in Blood

373

0.50

2.71

2.8

1.7

e9/l

1.2

1.0

0.45

232

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1130

10596

0.90

2.68

2.0

2.5

mmol/l

0.8

0.64

941

9594

(3017143) Hepatitis C virus Ab [Presence] in Serum

314

3219

0.83

2.67

1.3

1.4

—

(3019225) pH of Specimen

758

7262

0.89

2.64

4.1

4.5

—

(3006653) Thiamine [Moles/volume] in Blood

207

1.70

2.61

1.0

nmol/l

137.0

134.5

0.10

207

(21494434) Karyotype in Bone marrow

607

0.62

2.61

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

561

0.61

2.55

1.2

1.4

—

(21494755) Public health laboratory ask at order entry panel

157

0.33

2.54

1.2

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

592

0.62

2.54

1.2

1.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

423

4204

0.86

2.52

1.5

1.6

g/l

1.6

1.5

0.61

314

3565

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

113

1295

0.74

2.51

1.4

1.5

iu/ml

44.3

6.7

0.73

363

(40758558) Short blood count panel - Blood

1756

14053

1.09

2.50

4.7

6.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

322

3267

0.84

2.47

1.8

2.2

g/l

3.9

3.8

0.43

197

2214

(3004775) Volume in Urine collected for unspecified duration

619

0.63

2.47

2.3

2.1

705.7

631.5

0.50

378

(3036603) Volume of Urine

371

0.53

2.45

3.0

1.5

1439.0

1774.8

—

128

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

346

1.51

2.45

1.1

—

2.6

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

491

0.59

2.45

1.0

1.1

u/ml

279.4

308.4

0.21

277

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

0.00

2.45

0.0

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

638

0.64

2.44

1.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

302

0.48

2.43

1.1

u/l

123.3

92.2

0.42

224

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

302

0.48

2.43

1.1

u/l

73.0

33.1

—

217

(3037121) Protein [Mass/volume] in Urine

237

2471

0.82

2.43

2.2

2.6

g/l

0.3

0.04

911

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

395

3932

0.85

2.41

4.0

6.7

mmol/l

24.1

24.4

0.85

343

3554

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

614

0.64

2.39

1.1

1.2

u/l

51.3

61.1

0.70

411

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

325

3281

0.84

2.37

1.8

2.2

g/l

7.6

0.15

201

2287

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

2.17

2.35

1.1

1.2

26.4

49.8

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

147

1609

0.78

2.34

1.9

1.6

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

714

0.67

2.34

1.2

1.1

—

(40761536) Microorganisms panel - Urine sediment

519

5051

0.87

2.34

4.9

4.8

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

325

3276

0.84

2.33

1.8

2.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

536

0.62

2.31

1.1

1.4

—

(3004451) EKG impression Narrative

439

0.58

2.30

1.1

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

129

1431

0.77

2.29

2.7

2.5

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

931

0.72

2.28

1.3

—

(3003434) Protein [Mass/volume] in Pleural fluid

137

1506

0.78

2.27

1.4

1.5

g/l

30.0

30.4

0.14

118

1321

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

308

3111

0.84

2.27

1.8

2.2

g/l

10.5

10.4

0.07

222

2514

(3021901) Oxygen saturation in Capillary blood

155

1678

0.79

2.27

2.5

2.9

—

(3049717) Cytology report of Urine Cyto stain

345

3448

0.85

2.24

2.7

2.9

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

234

0.44

2.23

1.1

—

(4024509)

745

0.69

2.21

1.4

1.7

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

855

0.71

2.20

1.1

1.3

nmol/l

0.7

0.8

0.35

677

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

611

0.66

2.19

1.4

1.5

16.4

26.0

1.96

395

(3021879) Hepatitis B virus core Ab [Presence] in Serum

191

2010

0.81

2.18

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

239

1.58

2.17

1.1

1.3

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

209

2173

0.82

2.13

2.5

3.1

mmol/l

25.2

25.0

0.17

190

1894

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

1008

0.74

2.13

1.3

u/l

329.8

352.5

0.14

956

(3014111) Lactate [Moles/volume] in Serum or Plasma

833

6489

1.11

2.13

3.1

5.2

mmol/l

1.6

1.4

3.85

795

6155

(4211845)

364

0.56

2.12

3.3

4.3

—

(3021788) Differential panel - Synovial fluid

105

1182

0.76

2.11

1.4

—

(3016038) Potassium [Moles/volume] in Urine

531

1.37

2.10

1.1

mmol/l

35.1

34.2

0.13

435

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

0.00

2.09

0.0

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

776

0.70

2.08

1.5

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

531

0.64

2.07

1.1

1.0

—

(3000850) Epithelial cells [#/volume] in Urine

1863

15053

1.08

2.07

2.8

e6/l

5.6

5.1

1.01

1623

13182

(3007916) DNA double strand Ab [Titer] in Serum

0.00

2.07

0.0

1.1

—

100.8

—

(3017569) Oxygen content in Arterial blood

436

0.61

2.06

1.9

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

260

0.49

2.05

1.0

1.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

298

2985

0.85

2.02

1.9

2.3

g/l

3.2

0.31

198

2260

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

412

1.42

2.02

2.9

2.1

u/field

1.6

2.6

0.96

264

(3018405) Lactate [Moles/volume] in Arterial blood

375

2789

1.16

2.02

2.6

3.6

mmol/l

1.5

1.4

0.12

369

2732

(3040151) Glucose [Moles/volume] in Capillary blood

147

1004

1.26

1.96

6.9

8.7

mmol/l

7.5

7.4

0.12

116

818

(4027681)

120

1.79

1.95

1.1

1.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

129

1397

0.79

1.94

2.7

2.6

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

428

0.62

1.93

1.4

1.5

53.3

67.7

1.16

337

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

417

0.62

1.92

1.2

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

417

0.62

1.92

1.2

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

552

0.67

1.92

9.1

13.7

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

149

0.40

1.92

4.0

2.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.60

1.90

1.0

1.1

—

(3011648) Oxygen content in Venous blood

435

0.63

1.87

1.1

1.5

8.9

10.0

0.55

435

(3036782) Glucose [Moles/volume] in Pleural fluid

956

0.75

1.87

1.3

1.4

mmol/l

6.5

0.04

892

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

165

1729

0.81

1.86

2.1

2.2

ug/min

93.3

90.8

0.03

959

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1950

17604

0.94

1.86

4.4

5.1

21.6

22.7

2.79

967

9844

(3000034) Microalbumin [Mass/volume] in Urine

597

0.69

1.84

2.3

3.1

mg/l

46.8

36.3

0.23

456

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

515

0.66

1.83

1.3

1.4

—

(21494814) CD8 cells/100 lymphocytes in Specimen

157

0.44

1.82

4.5

1.7

—

(3023420) DNA double strand Ab [Units/volume] in Serum

389

0.62

1.81

1.1

1.2

—

27.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

237

1.52

1.81

1.1

—

(3045716) Anion gap in Serum or Plasma

346

0.59

1.80

1.6

1.7

mmol/l

8.4

9.2

0.74

280

(3033658) Prothrombin time (PT) actual/Normal

1823

14806

1.07

1.75

3.3

4.0

78.9

79.6

0.54

1759

14443

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.36

1.75

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.36

1.75

1.0

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.36

1.75

1.0

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

199

0.47

1.74

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

426

0.64

1.73

1.1

1.2

—

(4062490)

363

0.61

1.73

1.2

1.3

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

185

1.58

1.72

1.1

mg/l

49.3

46.5

0.13

151

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

548

0.69

1.72

1.2

1.1

u/ml

—

(3024471) HLA-A [Type]

0.00

1.71

0.0

1.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

154

0.44

1.70

1.4

1.3

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

113

1.75

1.70

1.1

1.3

ug/l

80.1

104.2

0.43

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

1.69

0.0

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

208

0.49

1.69

1.6

1.8

—

(3002385) Erythrocyte distribution width [Ratio]

4793

40041

1.05

1.68

25.0

24.6

14.1

14.2

1.77

4617

38926

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.64

1.67

1.4

1.2

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1010

9299

0.92

1.66

3.9

5.7

mmol/l

104.5

104.2

1.13

966

9071

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

414

3979

0.89

1.62

3.6

5.7

mmol/l

24.7

24.9

0.29

406

3920

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

229

2292

0.85

1.61

1.2

1.3

au/ml

48.5

55.7

—

(3037556) Urate [Mass/volume] in Serum or Plasma

215

0.52

1.60

1.4

1.5

—

(3000012) Reticulocyte production index

509

0.69

1.59

1.7

1.5

—

(3000475) Leukocytes [#/volume] in Synovial fluid

152

1576

0.82

1.59

1.6

e6/l

28406.5

15639.2

0.94

110

1127

(3020191) Ethanol [Moles/volume] in Serum or Plasma

238

1.48

1.58

1.1

1.2

promille

0.6

1.0

0.86

172

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

225

0.53

1.58

2.1

2.5

44.8

36.7

—

(3000991) Gas panel - Venous blood

661

6183

0.91

1.57

3.4

6.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

476

0.68

1.56

1.1

1.2

—

(3024932) HLA-DR beta [Type]

0.00

1.54

0.0

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

1.53

0.0

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

212

1.50

1.53

1.6

1.8

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5329

44699

1.05

1.53

5.3

7.3

u/l

83.1

84.2

0.52

4767

41482

(3024139) IgG subclass 3 [Mass/volume] in Serum

361

0.64

1.52

1.1

1.3

g/l

0.5

0.14

265

(3027135) IgG subclass 1 [Mass/volume] in Serum

361

0.64

1.52

1.1

1.3

g/l

6.4

7.2

0.56

260

(3028192) IgG subclass 2 [Mass/volume] in Serum

361

0.64

1.52

1.1

1.3

g/l

2.7

2.9

0.25

265

(3003327) Ova and parasites identified in Stool by Light microscopy

112

1192

0.80

1.52

1.5

1.6

—

(4146454)

750

0.75

1.51

2.3

2.6

—

(40767503) Oxygen content in Capillary blood by calculation

167

1706

0.84

1.51

2.5

2.6

16.4

15.4

1.98

914

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

456

3514

1.12

1.50

2.4

3.5

mmol/l

24.0

24.1

0.10

407

3123

(3008152) Bicarbonate [Moles/volume] in Arterial blood

632

4955

1.10

1.50

4.4

6.0

mmol/l

24.5

0.03

607

4631

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

816

0.76

1.49

2.4

3.6

u/ml

35.7

45.1

0.40

791

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

601

0.73

1.49

1.0

—

(3016750) Collection duration of Urine

420

0.67

1.48

2.4

1.9

min

498.1

499.2

0.02

288

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

274

0.59

1.48

2.9

1.7

13.4

15.2

—

106

(3001893) Eosinophils/100 leukocytes in Pleural fluid

368

0.65

1.47

1.4

1.5

4.4

2.8

0.35

299

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

529

0.71

1.46

1.2

u/ml

121.9

114.9

0.26

114

(44813793)

206

0.54

1.42

1.0

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

292

0.62

1.42

1.1

1.4

2.3

3.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

426

0.68

1.42

1.3

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

426

0.68

1.42

1.3

1.4

—

(44790049)

585

0.73

1.41

1.2

1.3

—

(44790047)

585

0.73

1.41

1.2

1.3

—

(44790048)

585

0.73

1.41

1.2

1.3

—

(44806118)

585

0.73

1.41

1.2

1.3

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

317

1.38

1.40

1.2

mmol/l

2.1

2.2

0.93

288

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

434

0.69

1.39

1.1

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

204

0.55

1.38

2.5

1.6

u/ml

960.1

1835.8

2.12

195

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

2.02

1.37

1.0

1.1

pmol/l

19.0

13.7

0.42

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.02

1.37

1.0

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1621

14575

0.94

1.36

4.6

4.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

278

0.62

1.36

2.9

1.8

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3654

32175

0.96

1.35

3.7

5.5

umol/l

13.1

12.8

0.51

3271

30300

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

240

1.43

1.34

1.1

—

(3042733) HLA Ab [Presence] in Serum

0.00

1.33

0.0

4.5

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

1.33

0.0

1.0

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

358

0.67

1.32

1.0

1.1

116.3

113.9

0.23

304

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

368

0.67

1.31

1.1

1.2

titre

110.0

126.9

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

790

0.78

1.31

1.2

1.3

u/l

22.5

12.1

0.98

726

(3026389) Candida sp identified in Specimen by Organism specific culture

770

0.78

1.30

1.2

1.5

—

(3051651) Icteric interference index of Serum or Plasma

411

1.32

1.29

3.4

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

113

0.45

1.29

1.0

1.1

—

13.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

113

0.45

1.29

1.0

1.3

—

133.2

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

115

0.45

1.29

1.0

1.1

—

2.0

—

(4306422)

366

0.68

1.28

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

220

0.58

1.28

1.1

1.0

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

709

0.77

1.26

1.3

1.4

u/l

14.3

14.0

0.17

673

(1616796) Gas panel - Central venous blood

184

1830

0.86

1.26

3.1

3.7

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

102

0.42

1.25

13.8

13.0

mmol/l

5.7

5.2

—

102

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

261

0.62

1.25

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

261

0.62

1.25

1.1

—

(3037756) Immunofixation for Serum or Plasma

188

1865

0.86

1.24

1.4

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

363

0.68

1.24

1.6

u/l

4.2

6.7

0.71

169

(40759836) Histone Ab [Presence] in Serum by Immunoblot

260

0.63

1.23

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

260

0.63

1.23

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

260

0.63

1.23

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

260

0.63

1.23

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

772

0.79

1.22

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

300

0.66

1.21

5.0

4.9

u/ml

139.1

155.6

—

(3035880) pH of Pleural fluid

588

0.76

1.21

1.2

1.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

217

1624

1.15

1.19

4.4

4.0

mg/l

33.0

30.7

0.35

162

1111

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

268

0.64

1.19

6.8

5.3

59.2

72.5

0.71

206

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

147

0.52

1.19

4.1

1.7

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

298

0.66

1.18

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

379

0.70

1.18

1.1

1.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

110

0.47

1.17

1.2

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

1.17

0.0

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.00

1.17

0.0

1.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

328

0.68

1.17

1.4

1.7

pmol/l

170.3

188.4

0.55

290

(40758358) Immune stain study

0.00

1.16

0.0

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

112

0.46

1.16

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

112

0.46

1.16

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

112

0.46

1.16

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

112

0.46

1.16

1.0

1.1

—

(36660697) Celiac disease serology panel - Serum

326

3103

0.90

1.16

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

437

0.72

1.16

1.2

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

241

1.39

1.15

1.9

2.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

241

1.39

1.15

2.0

2.2

—

(3012565) Volume of 24 hour Urine

254

0.64

1.13

2.1

2.3

1680.0

1777.0

0.13

203

(3048879) Bone marrow aspiration report

254

0.64

1.13

1.1

1.3

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

128

1.54

1.13

1.3

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

365

0.70

1.12

1.1

1.2

u/l

109.3

100.6

0.14

314

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

589

1.24

1.12

1.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

434

0.73

1.12

3.1

2.7

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

189

0.59

1.10

1.2

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

121

0.50

1.09

5.1

2.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

241

0.64

1.09

6.1

5.7

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

2.38

1.07

1.6

1.1

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

633

5818

0.93

1.07

1.6

1.9

g/l

0.2

0.60

532

5261

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

198

0.61

1.07

2.1

1.9

—

(3008295) Osmolality of Serum or Plasma

655

1.22

1.07

1.4

1.3

mosm/kgh2o

274.9

273.8

0.14

452

(3010375) cycloSPORINE [Mass/volume] in Blood

107

0.48

1.05

22.7

22.1

ug/l

85.5

98.4

—

(40768806) Pleura Pathology biopsy report

111

1129

0.84

1.04

1.4

1.6

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

127

0.54

1.04

2.9

2.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

131

1313

0.85

1.04

1.4

1.5

e6/l

3352.4

1928.7

0.44

962

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2499

22073

0.96

1.03

4.5

5.8

ug/l

8.0

5.8

0.43

2092

19114

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

932

0.83

1.03

1.3

1.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

285

2710

0.90

1.03

1.8

2.4

g/l

1.4

1.3

0.08

206

2209

(3028717) Thiamine [Mass/volume] in Blood

1.93

1.02

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

581

1.23

1.02

1.3

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

104

1.57

1.02

2.3

2.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

436

0.75

1.02

1.1

1.2

u/ml

1.6

4.3

—

131

(3019420) Tryptase [Mass/volume] in Serum or Plasma

152

0.56

1.01

1.9

1.4

ug/l

9.9

10.1

—

135

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

375

0.73

0.99

1.1

1.2

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

0.98

0.0

12.6

—

268.1

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

138

0.56

0.98

1.4

umol/l

28.7

29.6

—

131

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

578

0.78

0.98

1.2

—

(4268621)

265

0.68

0.98

2.0

2.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

345

0.72

0.98

1.5

1.7

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

126

1.50

0.98

1.0

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

1.84

0.98

1.0

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.97

0.0

1.3

—

(3019174) dRVVT (LA screen)

0.00

0.97

0.0

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

131

1304

0.86

0.97

1.5

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

0.95

0.0

1.8

—

1.3

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

0.00

0.95

0.0

6.5

—

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

431

0.75

0.95

1.9

1.7

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

212

0.65

0.95

1.3

1.1

u/ml

0.4

0.9

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

641

5856

0.93

0.94

2.7

3.4

ng/l

86.4

101.1

4.19

497

4764

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

102

0.50

0.94

6.5

8.2

—

(3012441) Differential panel - Pleural fluid

113

1135

0.85

0.94

1.5

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

201

0.64

0.94

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

201

0.64

0.94

1.0

—

(3022689) Creatine [Moles/volume] in Urine

123

0.56

0.94

1.3

1.4

—

(40768446) Kidney Pathology biopsy report

104

0.49

0.94

1.0

1.4

—

(44806071)

2.24

0.93

1.3

1.1

—

(3013707) Erythrocyte sedimentation rate by Westergren method

4708

41031

0.97

0.93

3.6

4.4

mm/h

16.9

16.7

0.27

4049

36972

(3024354) Oxygen [Partial pressure] in Venous blood

786

6358

1.06

0.93

2.3

3.1

kpa

4.1

4.3

2.57

737

6108

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

431

3994

0.92

0.93

2.9

4.3

46.4

45.8

0.25

424

3949

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.78

0.92

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

628

0.80

0.91

1.3

e6/l

260253.3

205789.9

0.16

426

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.48

0.90

1.0

1.3

—

1.6

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

131

0.59

0.89

1.2

1.5

ng/l

146.5

129.5

—

131

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

416

0.76

0.89

1.1

1.2

u/ml

7.0

4.7

0.29

193

(3011288) Drugs identified in Urine by Screen method

1.90

0.88

1.3

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

766

0.83

0.88

1.3

1.4

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

287

0.72

0.86

1.0

1.1

mmol/l

13.2

12.0

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

226

2150

0.90

0.86

1.9

2.3

g/l

0.0

0.00

182

1941

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

246

2329

0.90

0.86

1.8

2.3

g/l

0.0

0.1

1.36

194

2076

(3002619) Bacteria identified in Specimen by Culture

144

0.59

0.85

1.4

1.2

—

(40757494) Bilirubin.total [Moles/volume] in Blood

383

0.76

0.84

1.7

2.1

umol/l

19.1

21.0

—

(3025130) Human papilloma virus identified in Specimen

195

0.66

0.84

2.3

1.5

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

0.53

0.83

1.0

1.1

—

(3023383) Lactate [Moles/volume] in Pleural fluid

324

0.74

0.83

1.2

1.3

mmol/l

4.8

3.4

0.97

293

(3025018) Bordetella pertussis Ab [Titer] in Serum

142

0.60

0.82

1.2

1.3

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

352

0.75

0.81

1.1

1.2

u/l

36.3

32.3

0.14

296

(3022229) Phosphate [Moles/volume] in Urine

0.00

0.80

0.0

1.1

—

16.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

282

0.73

0.79

1.0

1.1

95.3

89.7

0.57

253

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

379

0.77

0.79

1.0

1.1

—

(3044927) Protein electrophoresis panel - Urine

922

0.85

0.79

1.3

1.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

232

2190

0.91

0.78

1.9

2.3

g/l

0.0

1.01

182

1950

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

105

1.47

0.77

2.3

2.2

—

(3026470) Cobalt [Mass/volume] in Blood

482

0.80

0.77

1.8

ug/l

2.7

4.3

0.99

414

(3028433) Virus identified in Specimen by Culture

180

0.67

0.76

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

200

0.68

0.75

1.1

1.2

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

249

0.72

0.74

1.2

1.4

17.9

21.9

0.27

201

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

249

0.72

0.74

1.1

—

(3020891) Body temperature

385

3069

1.08

0.74

3.2

4.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

194

1.33

0.74

1.3

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

335

3098

0.92

0.73

2.1

2.5

u/ml

0.4

0.3

0.55

188

1804

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

460

0.80

0.73

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

107

796

1.15

0.73

2.7

2.4

u/field

2.5

2.4

0.08

237

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

315

0.76

0.71

1.3

ug/l

984.1

294.5

0.36

174

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

615

1.17

0.71

1.3

titre

327.3

351.6

0.05

(4198724)

1.95

0.71

1.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1.57

0.70

1.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

395

3622

0.93

0.70

1.2

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

400

0.79

0.70

1.0

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

400

0.79

0.70

1.0

1.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

226

0.72

0.70

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

634

0.84

0.69

1.4

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

360

0.78

0.68

1.4

1.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

124

1199

0.88

0.67

1.4

e6/l

30663.9

60247.4

1.85

725

(3038177) Helicobacter pylori Ab [Presence] in Serum

548

0.83

0.67

1.7

1.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

407

0.80

0.67

1.2

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

154

0.67

0.66

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

133

0.64

0.65

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

106

797

1.14

0.65

3.2

3.4

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

161

1.33

0.65

1.0

1.1

—

(3026782) Osmolality of Urine

1757

14638

1.03

0.64

3.0

3.1

mosm/kgh2o

565.5

537.3

7.51

1438

12397

(3036670) Protein [Mass/volume] in Synovial fluid

242

0.74

0.64

1.2

g/l

40.1

39.7

0.07

110

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

273

2528

0.92

0.64

1.8

2.2

g/l

36.1

36.5

0.40

193

2050

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

502

4548

0.94

0.64

3.7

6.8

0.8

0.7

4.25

497

4505

(3044889) 12 lead EKG panel

4412

38329

0.97

0.63

4.5

4.8

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

132

0.65

0.63

5.1

1.6

156.6

184.2

—

117

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

875

0.87

0.63

4.7

5.6

mg/l

13.2

12.9

0.21

781

(3024928) Oxygen saturation in Venous blood

183

1426

1.10

0.62

1.6

2.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.57

0.62

1.0

1.1

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

0.57

0.62

1.0

1.2

—

11.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

542

0.84

0.61

1.1

1.0

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

181

0.71

0.61

2.4

mmol/l

6.9

7.5

—

123

(3041918) Cholesterol [Moles/volume] in Pleural fluid

171

0.70

0.61

1.0

1.2

mmol/l

1.8

1.4

—

104

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.61

0.0

1.2

—

263.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.61

0.0

2.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

210

0.73

0.61

1.2

1.8

e6/l

832.4

3594.1

—

148

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

844

0.87

0.60

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

180

0.71

0.60

1.0

u/ml

2.5

0.8

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

400

0.81

0.59

1.1

—

(3027315) Oxygen [Partial pressure] in Blood

190

1779

0.91

0.59

3.7

4.5

kpa

7.8

8.2

2.40

179

1718

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

747

1.14

0.59

1.9

1.6

u/ml

33.5

26.4

0.77

165

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

413

3753

0.94

0.59

2.1

2.5

0.7

1.95

397

3610

(3045788) Cell count panel - Pleural fluid

104

1003

0.89

0.57

1.6

1.5

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.66

0.56

1.0

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

274

0.78

0.56

1.0

1.3

nmol/l

1.4

1.2

0.59

204

(3020650) Glucose [Presence] in Urine

106

0.65

0.55

3.1

1.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

377

3422

0.94

0.54

1.9

2.0

—

(3013290) Carbon dioxide [Partial pressure] in Blood

191

1774

0.92

0.52

3.7

4.5

kpa

5.0

0.13

181

1713

(3015183) Erythrocyte sedimentation rate

0.61

0.52

1.0

1.6

—

(3012501) Base excess in Blood by calculation

191

1772

0.92

0.51

3.7

4.5

mmol/l

2.8

2.9

0.22

130

1219

(3003181) Sodium [Moles/volume] in Urine

195

1543

1.08

0.51

1.3

mmol/l

63.6

60.7

0.50

154

1231

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

597

1.13

0.49

1.3

titre

58.3

51.2

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

191

0.76

0.47

1.2

1.7

e6/l

2452.6

20228.3

—

112

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6336

53883

1.02

0.47

8.9

11.4

u/l

22.1

22.4

0.23

5808

51012

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

238

0.79

0.47

1.0

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

1.48

0.47

1.1

1.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

100

0.69

0.46

1.0

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.59

0.46

1.0

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

328

1.18

0.46

1.1

1.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

674

1.12

0.46

1.4

1.6

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

141

0.73

0.45

1.1

1.0

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2209

19275

0.98

0.45

2.2

2.5

u/l

59.0

60.2

0.41

1970

17581

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

103

1.33

0.45

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

236

0.80

0.44

1.0

1.2

—

(3036489) Thrombin time

193

1775

0.93

0.44

1.7

21.0

22.2

1.22

179

1617

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.59

0.42

1.2

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.59

0.42

1.0

1.1

—

(3034426) Prothrombin time (PT)

0.63

0.42

1.0

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

193

1770

0.93

0.42

1.3

1.4

ug/g

264.8

260.0

0.12

1118

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

6.5

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

0.41

0.0

1.0

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.7

—

2.7

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

129

0.73

0.41

1.1

umol/24h

0.5

0.6

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.41

0.0

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.41

0.0

1.5

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.00

0.41

0.0

1.9

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

873

7701

0.97

0.40

2.5

3.5

kpa

5.9

5.8

0.65

822

7432

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

408

0.86

0.40

1.1

1.2

nmol/l

1.0

1.4

3.14

363

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.40

0.0

2.0

—

17.7

—

(3051339) Copper [Moles/volume] in Blood

0.00

0.40

0.0

1.3

—

18.7

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

0.68

0.40

1.6

1.2

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

426

0.86

0.39

1.0

1.1

—

11.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.67

0.39

1.0

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

1.38

0.38

1.0

—

(3027008) Opiates [Presence] in Urine

1.35

0.38

1.0

—

(3028300) Cannabinoids [Presence] in Urine

1.33

0.38

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

174

0.79

0.37

6.4

5.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

153

1.23

0.37

1.0

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

352

3152

0.96

0.36

1.9

1.8

—

(3047181) Lactate [Moles/volume] in Blood

242

2188

0.95

0.36

3.7

5.2

mmol/l

1.4

0.28

219

1947

(3000285) Sodium [Moles/volume] in Blood

125

0.75

0.35

1.6

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

108

0.71

0.35

1.4

1.5

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.39

0.35

1.2

—

(3025577) Chromium [Mass/volume] in Blood

466

0.88

0.35

1.9

2.0

ug/l

1.8

2.2

0.43

383

(3002032) Base excess in Venous blood by calculation

872

7670

0.97

0.35

2.5

3.5

mmol/l

2.0

1.9

0.29

693

6139

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

195

1772

0.94

0.34

1.0

1.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

892

7447

1.03

0.34

1.7

1.8

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3291

28502

0.98

0.32

2.7

3.1

u/l

52.5

58.2

2.27

2790

25251

(3016502) Oxygen saturation in Arterial blood

892

7833

0.97

0.32

3.6

5.7

94.5

95.0

0.98

857

7485

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

161

0.80

0.32

1.7

2.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

156

1.21

0.32

1.0

—

(21491868) Cryoglobulin [Mass/volume] in Serum

170

0.81

0.32

1.2

g/l

—

0.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

309

2535

1.05

0.32

2.4

3.0

pmol/l

4.3

4.2

0.64

244

2132

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

160

0.80

0.31

1.4

pmol/l

17.1

17.0

—

117

(3036071) Salmonella sp Ab [Titer] in Serum

0.71

0.31

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.71

0.31

1.6

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

122

0.77

0.30

1.0

1.2

mmol/l

1.2

2.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

202

1824

0.95

0.30

2.1

2.3

g/l

126.1

123.9

0.60

162

1357

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

729

0.92

0.30

2.4

3.0

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

790

6939

0.97

0.30

3.7

6.1

g/l

120.5

118.0

2.85

767

6692

(3029634) Reagin Ab [Titer] in Serum by VDRL

335

1.13

0.29

1.2

1.3

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

214

0.84

0.29

1.0

1.3

umol/l

5.8

15.0

1.80

143

(3044242) Glucose [Moles/volume] in Arterial blood

433

1.11

0.29

1.5

1.7

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

100

0.77

0.27

1.0

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

303

0.88

0.27

1.0

2.4

mg/l

58.6

66.6

0.35

195

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2742

23740

0.99

0.26

2.6

3.0

ug/l

139.9

157.1

2.79

2342

20994

(3016879) Cocaine [Presence] in Urine

1.20

0.26

1.0

—

(4212803)

1.27

0.26

1.2

1.0

—

(3019060) Gas panel - Arterial blood

641

5355

1.03

0.26

3.1

4.0

—

(3044941) Cell count panel - Synovial fluid

112

1023

0.94

0.26

1.4

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

266

1.13

0.25

1.0

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.19

0.24

1.8

1.7

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

363

0.90

0.24

2.7

3.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

104

837

1.07

0.24

1.8

1.6

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.34

0.23

1.0

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

245

0.87

0.23

2.3

2.9

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

135

0.82

0.22

1.0

1.1

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

135

0.82

0.22

1.2

1.3

80.4

75.8

—

116

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

0.76

0.22

1.6

1.1

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

0.2

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.21

0.0

5.7

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.21

0.0

9.3

—

56.1

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

243

0.88

0.21

1.2

1.3

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(36303858) Crystals [Presence] in Urine

0.00

0.21

0.0

1.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.00

0.20

0.0

1.1

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.20

0.0

1.0

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.20

0.0

1.4

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.00

0.20

0.0

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.20

0.0

1.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

133

0.84

0.20

1.1

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

114

0.83

0.19

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

125

1.17

0.19

1.1

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1177

9949

1.02

0.19

2.0

2.2

1.7

1.8

0.29

904

8567

(3020491) Glucose [Moles/volume] in Blood

444

0.93

0.18

2.0

2.4

mmol/l

6.9

7.3

0.62

295

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.18

0.18

1.0

1.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

772

6510

1.02

0.17

2.1

2.5

umol/l

11.2

10.1

0.50

605

5604

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.11

0.17

12.4

14.9

—

(3022621) pH of Urine by Test strip

523

4395

1.02

0.16

4.1

3.8

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

130

0.86

0.16

1.1

1.0

—

(3003396) Base excess in Arterial blood by calculation

1041

8807

1.01

0.16

3.5

5.5

mmol/l

1.2

0.02

779

6687

(3019897) Erythrocyte distribution width [Ratio] by Automated count

1.11

0.16

10.8

12.8

14.0

14.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

590

0.94

0.15

1.7

1.4

mg/l

1.8

2.9

1.29

455

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

228

0.90

0.15

1.4

u/l

5.0

6.5

1.00

185

(3006576) Bicarbonate [Moles/volume] in Blood

251

1.09

0.15

3.1

6.1

mmol/l

24.7

24.4

0.17

227

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

0.78

0.14

1.0

1.4

umol/l

2.3

2.0

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

137

1.13

0.14

1.1

1.3

g/l

27.8

70.5

0.53

111

(40762814) Titanium [Mass/volume] in Blood

128

0.87

0.13

2.2

1.9

ug/l

2.9

3.4

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

115

1023

0.96

0.13

1.8

2.2

mg/l

35.6

27.0

0.65

236

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

921

7982

0.99

0.13

3.2

3.3

ng/l

271.3

304.1

1.23

839

7319

(3024263) Appearance of Synovial fluid

353

1.07

0.13

1.5

1.6

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.84

0.13

1.7

1.5

umol/l

51.1

48.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.84

0.13

1.2

1.5

ug/l

8.5

9.8

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

118

0.87

0.12

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

180

0.90

0.12

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.16

0.12

3.3

5.0

—

(3019977) pH of Arterial blood

505

0.95

0.11

1.9

2.2

7.4

0.24

205

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

117

0.88

0.11

1.3

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

125

0.89

0.10

1.2

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

326

0.95

0.09

1.9

2.4

—

(1002224) Polysomnography panel

570

1.04

0.08

1.1

—

(44786800) Granulocytes/100 leukocytes in Body fluid

159

0.92

0.08

1.4

30.0

20.2

—

123

(3025549) Creatine [Moles/time] in 24 hour Urine

0.82

0.08

1.4

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

185

0.93

0.08

1.1

—

(3027944) Amphetamines [Presence] in Urine

1.09

0.08

1.0

—

(3020874) Milk IgE Ab [Units/volume] in Serum

0.84

0.07

1.0

1.1

—

0.4

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

184

0.93

0.07

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

140

0.92

0.07

1.1

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

0.89

0.07

4.3

1.7

179.4

211.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

126

1.09

0.07

1.1

—

15.8

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.90

0.06

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.89

0.06

1.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

0.87

0.06

1.2

1.8

ug/l

1.6

1.5

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

104

0.91

0.06

1.1

1.2

u/l

17.4

17.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

313

0.96

0.06

1.6

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

530

4576

0.99

0.06

1.6

2.0

nmol/l

408.8

387.3

1.56

436

4075

(3027456) Digoxin [Moles/volume] in Serum or Plasma

314

2663

1.01

0.05

3.6

3.3

nmol/l

0.8

0.52

238

2056

(3017704) Immunofixation for Urine

451

0.97

0.05

1.4

1.3

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

147

0.93

0.05

1.3

1.1

u/l

1.0

1.2

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1252

10772

1.00

0.05

1.7

1.9

29.7

30.3

2.43

1197

10421

(3025941) Bacteria identified in Stool by Culture

332

2821

1.01

0.04

1.3

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

410

3489

1.01

0.04

1.7

1.8

ug/l

3.8

2.3

0.59

302

2922

(3044007) Cell count panel - Peritoneal fluid

163

0.95

0.04

1.5

1.9

—

(3052851) Hemolysis interference index of Serum or Plasma

261

2255

0.99

0.04

3.4

3.7

—

(3029075) Extractable nuclear Ab panel - Serum

102

0.92

0.03

1.2

1.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

110

956

0.99

0.03

1.4

1.5

iu/l

2.8

4.2

1.31

254

(3013166) Neutrophils/100 leukocytes in Synovial fluid

214

1.04

0.03

1.3

1.4

74.8

64.7

1.03

186

(3032773) Endomysium IgG Ab [Titer] in Serum

317

1.03

0.02

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

127

0.94

0.02

1.1

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

144

0.95

0.02

2.5

2.2

—

27.8

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

467

4016

1.00

0.02

3.3

2.9

e6/l

0.4

0.3

0.52

456

3949

(3027801) Oxygen [Partial pressure] in Arterial blood

1025

8800

1.00

0.02

3.5

5.5

kpa

11.3

11.5

0.52

961

8250

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

549

1.01

0.02

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

114

1.05

0.01

1.1

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1026

8803

1.00

0.01

3.5

5.5

kpa

4.9

5.0

5.71

961

8258

(3039000) Anion gap in Blood

181

1556

1.00

0.00

3.9

5.7

mmol/l

11.3

0.05

167

1394

(3018572) Chloride [Moles/volume] in Blood

181

1556

1.00

0.00

3.9

5.7

mmol/l

104.3

104.7

0.52

167

1394

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

124

0.97

0.00

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

239

1.00

0.00

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

122

0.98

0.00

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

126

1.02

0.00

1.3

1.2

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

160

1.02

0.00

1.2

1.3

22.8

29.2

0.39

105

(3033799) Differential panel - Peritoneal fluid

187

1.01

0.00

1.3

1.7

—

(3010421) pH of Blood

235

2016

1.00

0.00

3.4

4.3

7.4

0.23

181

1715

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

1.0

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.2

—

49.6

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

1.0

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.01

0.00

1.0

1.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.0

3.8

—

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

0.00

0.0

5.6

—

14.0

—

(3013762) Body weight Measured

0.00

0.0

1.0

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

0.0

1.0

—

18.2

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.4

—

1.5

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.0

1.2

—

3.4

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.0

2.0

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

0.0

2.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.02

0.00

1.0

—

(3025315) Body weight

0.89

0.00

7.0

5.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

0.93

0.00

1.8

1.6

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

0.0

1.2

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.0

2.3

—

2.5

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.92

0.00

1.0

1.1

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

0.0

1.0

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

0.88

0.00

1.0

1.3

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.84

0.00

1.0

1.1

umol/24h

1.6

1.7

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

0.91

0.00

1.3

1.1

—

(3001729) Color of Synovial fluid

1.00

0.00

1.9

1.6

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.0

1.0

—

8.8

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

0.0

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

0.0

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.94

0.00

1.0

1.2

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.0

1.0

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.0

1.1

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

0.99

0.00

1.9

1.7

1.6

0.7

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.97

0.00

1.3

1.2

u/l

8.5

10.3

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.97

0.00

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.93

0.00

1.3

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.0

19.6

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

0.95

0.00

1.3

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

0.0

1.0

—

(3016135) IgD [Mass/volume] in Serum

0.00

0.0

1.2

—

74.2

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

5.1

—

338.3

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

1.8

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: AD_LO – Alzheimer’s disease (Late onset)

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Alzheimer’s disease (Late onset)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Alzheimer’s disease (Late onset) (AD_LO)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints